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Group 1 major urinary protein (Mu?) genes can be divided 
into subgroups named Mup-1.1A, Mup-1.1B, Mup-1.1C and Mup-
1. 1D. Allelic genes in Balb/c and C57BL/6 inbred strains of 
mice are referred to as Mup- 1. 1AR and Mup_1.lAk respective-
ly. Expression of MUP genes in the liver is sexually 
dimorphic, however, the relative expression in males and 
females varies between subgroups and between allelic genes 
within a subgroup. Genes from two subgroups, Mup-1.1A and 
Mup-1. 1C code for proteins which are synthesized at higher 
levels in male than female liver. In contrast, genes 
from two other subgroups, Mup-1.1B and Mup-1.1D code for 
proteins synthesized in male liver but undetectable in 
female liver. The Mup-1.1C subgroup contains two single 
copy allelic genes, Mup-1.10 and Mup_1.1Cb_. In C57BL/6 
expression of Mup-1.1cP in the liver of males is twice as 
high as females, whereas in Balb/c, expression of Mup-1. 1Cc-
in males is seven to twenty times as high as females. 
Several genes in the Mup-1.1B subgroup differ between 
Balb/c and C57BL/6 mice, however, expression in the liver 
ofenes in this subgroup is the same in both strains and 
is approximately one hundred times higher in males than 
females. 
In the livers of growth hormone (GH) deficient lit/lit 
C57BL/6 mice MUP mRNA levels are approximately one hundred 
fold lower than in phenotypically normal lit/+ C57BL/6 
males. The sexually dimorphic pattern of MU? expression is 
also absent. Administration of GH to male lit/lit mice by 
one regime caused a large increase in the levels of 
particular MU? mRNAs in the liver, whereas administration 
by another regime did not. Altering the GH regime affected 
some MU? mRNAs more than others. 
xv 
INTRODUCTION 
LIVER SPECIFIC GENE 
The liver is a widely used organ in the study of cell specific gene 
expression. This is largely due to its technical ease of isolation and 
its near homogeneity of cell type. As with any organ the liver's 
structure is an integral part of its function and this must be 
considered when model systems are designed for the study of liver 
specific gene expression. 
The liver is made up of many lobules which surround central venules. 
Capillary branches of the hepatic artery and hepatic portal vein lie 
on the outer edge of each lobule. Blood frn the hepatic portal vein 
and hepatic artery enters the hepatic sinusoids. There is only one 
layer of hepatocytes between sinusoids and the plasma is in close 
contact with these cells. The sinusoids feed the central veins which 
drain into the inferior vena cava. There are two main cell types in the 
liver, Kupffer cells and hepatocytes. Kupffer cells are derived from 
monocytes which enter tissues to become tissue macrophages. They form 
a secondary defence against bacteria. }iepatocytes are specialized liver 
cells which are derived from the endoderm and they are responsible for 
specialized functions of the liver which are listed in table 1.1. The 
sides of hepatocytes in vivo are adjacent to either the sinusoids, bile 
duct or other hepatocytes. 
During development immature hepatocytes become quiescent cells, however 
liver damage results in cell division (Shafritz et al., 1990; Sobczak 
et al., 1989). Following regeneration the hepatocytes again become 
quiescent cells. The pattern of hepatocyte gene expression changes 
during development. Some genes are expressed in the foetus but not in 
the adult, while others are switched on at birth or during postnatal 
1 
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Table 1.1 Functions of the liver 
formation of bile 
carbohydrate storage and release 
formation of urea 
synthesis of plasma proteins 
many functions related to the transport and metabolism of 
fat 
reduction and conjugation of adrenocorticoid and gonadal 
steroid hormones 
detoxification of many drugs and toxins 
development (Gluecksohn-waelsch, 1987; Powell et al., 1984; Derman, 
1981; Camper et al., 1989). Gene expression in hepatocytes is also 
altered during an inflammatory response called the acute phase 
(reviewed by Baumann et al., 1989; Schreiber et al., 1989). This is an 
acute change in gene expression which results in the synthesis of 
plasma proteins involved in minimizing tissue damage during inflamma-
tion and cell death. 
The different patterns of liver specific expression often result from 
differential gene transcription and subsequentially changes in 
transcription factors. There are a number of liver specific transcrip-
tion factors, the activity of which can be modulated by interaction 
with other transcription factors. Some of these are activated in 
response to hormonal stimulation. 
Model Systems For Studying Liver Specific Gene Expression 
Model systems used to characterize the molecular basis of liver 
specific gene expression are often limited in their ability to imitate 
the in vivo hepatocyte. The organization of the cells in the in vivo 
liver is in some way necessary for full expression of liver specific 
genes. When this supracellular organization is disrupted, the capacity 
of the cells to express these genes is reduced or even abolished. For 
example only limited liver specific gene expression occurs in hepatoma 
cells (Knowles et al., 1980; Deschatrette and Weiss, 1974; Szpirer et 
al., 1979) or primary hepatocyte cultures (Grieninger, 1983; Clayton 
and Darnell, 1983). Although more liver specific gene expression occurs 
when primary hepatocytes are grown on matrigel (Friedman et al., 1989b; 
Schuetz et al., 1988) or feeder cells (Fraslin et al., 1985,), a direct 
effect of the cell matrix on transcription has not yet been proved 
(Bissel et al., 1990). Some liver specific genes have been studied in 
transgenic animals where the normal liver environment is maintained. 
A further advantage of transgenic animals compared with isolated cells 
in culture is that one can study the expression of the transgene in 
several tissues simultaneously (Idzerda et al., 1989; Kruznlauf et al., 
1985; Hammer et al., 1987; Ian et al., 1990; Al-Shawi et al., 1988). 
Transgenic animals suffer from several disadvantages compared with 
cells in culture, the largest of which is the amount of time required 
to analyse a large number of gene constructs. 
Transcriptionally competent liver nuclear extracts have been used to 
identify sequences which are important for the transcription of a 
number of liver specific genes (Gorski et al., 1986). The information 
from functional studies in these extracts can be combined with gel-
shift assays and in vitro and in vivo footprinting assays to derive a 
picture of the functionally active factors which can bind to the gene 
3 
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of interest (Grayson et al., 1989; Mirkovitch and Darnell, 1991). 
Nuclear extracts have a large advantage over transgenic animals because 
a number of deleted or mutated constructs of the gene of interest can 
be easily analysed. 
Ultimately a combination of many systems may be needed to identify all 
of the elements involved in liver specific gene expression. For example 
147bp of the albumin proximal promoter is sufficient to allow liver 
specific expression in nuclear extracts (Gorski et al., 1986; 
Lichtsteiner et al., 1987), whereas 12kb of the proximal promoter are 
required to allow expression of an albumin transgene in mice (Pinkert 
et al., 1987). Expression was achieved in transgenic mice from a 
construct containing the -10kb far upstream element fused to the 
proximal element. This indicates that the sequence of the far upstream 
element was important and not its position relative to the transcrip-
tion start site (Pinkert et al., 1987). Using nuclear extracts, Vaulont 
et al., (1989) were unable to achieve a hormonal response seen in vivo. 
The hormonal response element was located more than 300bp upstream of 
the TATA box and the inability of this element to work in vitro may be 
due to differences in the folding of DNA in nuclear extracts compared 
with in viva. 
Liver specific transcription factors can sometimes be identified by 
characterizing mice carrying mutations which affect some aspects of 
liver specific gene expression. The mutated genes are likely to have 
some role in liver specific gene expression. Mice carrying the mutant 
alleles nt, rat and alt have different timing of liver specific gene 
expression during development. Nice with the nit allele fail to express 
a-fetoprotein during liver regeneration (Abelev, 1971) whereas those 
with the rat allele continue to express the foetal genes a-foetoprote- 
eoi. 	 eEo.L. 
in, and H19 at birth (0lsson, , 1977; Pachnisk  1984). Mice with the alt 
4 
allele fail to turn on a set of cAMP and glucocorticoid regulated 
enzymes at birth (Ruppert et al., 1990). A particular gene product is 
likely to be absent or altered due to each of these mutations and this 
could be identified. 
When hepatoma cells are fused to other cell types the expression of 
liver specific genes is switched off in a process called extinction. 
Extinction is controlled by genetic loci acting in trans and can be 
reversed if certain chromosomes are lost from the cell hybrids (Chin 
and Fournier, 1989; Petit et al., 1986; Peterson et al., 1985). A locus 
called Tse 1 is responsible for extinction of some liver specific gene 
expression (Thayer and Fournier, 1989; Lem et al., 1988). Tse 1 is 
thought to interfere with the transcription of genes which respond to 
cAMP by interfering with the binding of transcription factors to the 
cAMP response element (Ruppert et al., 1990; Boshart et al., 1990). 
Liver-Specific Transcription Factors 
Using a combination of in vitro and in viva analysis, a number of 
transcription factors involved in liver specific gene expression have 
now been characterized, isolated and in some cases cloned. The first 
of these to be cloned was C/EBP (Landschutz et al., 1988). C/EBP is a 
liver factor which is also found in a number of other tissues. Its 
distribution in gut, lung, placenta, adrenals and liver led to the 
suggestion that it is involved in the regulation of lipid metabolism 
(McKnight et al., 1989). The expression of C/EBP is developmentally 
controlled being maximum at birth and falling postnatally. Hence it 
could be involved in the developmental control of gene expression 
(Birkenmeier et al., 1989). C/EBP is not found in dedifferentiated 
hepatocytes or preadipocytes, but is expressed only in differentiated 
5 
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cells (Birkenmeier et al., 1989; Christy et al., 1989). In differ-
entiating 3T3-F442A preadipocytes the expression of C/EBP occurs at the 
same time as genes specific to the differentiated phenotype (Christy 
et al., 1989). This is consistent with the involvement of C/EBP in the 
control of transcription of genes expressed in differentiated cells. 
In nuclear extracts, dEEP acts as a positive transcription factor 
which stimulates transcription from promoters linked to an upstream 
C/EBP response element (Friedman et al., 1989). When it is expressed 
in hepatorna cells it can activate specific liver genes (Friedman et 
al., 1989). C/EBP binds to a wide range of different DNA sequences, 
through which it can activate transcription. Consensus sequences 
include CCAAT boxes and enhancer core sequences (Johnson et al., 1987; 
Graves et al., 1986). CCAAT boxes are found in the 5' regions of almost 
all genes and are bound by a family of CCAAT box binding proteins of 
which C/EBP is a member (reviewed by Johnson and McKnight 1989; 
Raymondjean et al., 1988; Chodosh et al., 1988). In order to activate 
transcription in vivo C/EBP may have to displace another CCAAT box 
binding protein. 
The structure of C/EBP provides some clues to how it functions. It 
contains a leucine zipper structure which is essential for its activity 
(Christy et al., 1989). Leucine zippers are involved in dimerization 
and C/EBP can form homodimers and also heterodimers with other leucine 
zipper proteins (Roman et al., 1990). Binding sites for C/EBP are found 
adjacent to APi sites which are binding sites for its- jun heterodimers 
(reviewed by Johnson and McKnight, 1989). Fos and jun are also leucine 
zipper transcription factors which may interact with C/EBP and modulate 
its activity. A leucine zipper protein related to C/EBP was activated 
during the acute phase response (Akira et al., 1990). 
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The second liver specific transcription factor to be cloned was HNF-i 
also called LF-B1, APP and HP-1 (Frain et al., 1989; Courtois et al., 
1987; Hardon et al., 1988; Monaci et al., 1988; Cereghini et al., 1988; 
Schorpp et al., 1988). HNP-1 mRNA was detected in kidney, intestine, 
spleen and thymus and functionally active protein was detected in 
nuclear extracts from liver and kidney (Frain et al., 1989; Baumheuter 
et al., 1990). HNF-i activates a large number of liver genes and is 
expressed in differentiated but not dedifferentiated hepatocytes 
(Cereghini et al., 1988; Baumheuter et al., 1988). HNF-1 acts as a 
positive transcription factor by binding to a highly conserved inverted 
repeat sequence GTTAATNATTAAC (Courtois et al., 1988). HNF-i binding 
sites are invariably found within 150 base pairs 5' of the transcripti-
onal start site (Courtois et al., 1987; Cereghini et al., 1988; Hardon 
et al., 1988; Lichtsteiner et al., 1987; Grayson et al., 1988; Costa 
et al., 1988; Tsutsumi et al., 1989; Vaulont et al., 1989; Frain et 
al., 1990). The single known exception is a second site in the human 
albumin promoter between -360 and -344 (Courtois et al., 1988). A 
single HNF-1 binding site within 150 base pairs of the transcriptional 
start site and a TATA box can direct liver specific expression in 
nuclear extracts (Ryffel et al., 1989). The position seems to be 
important for the function of HNF-1. If the HNF-1 site is moved more 
than 400bp from the TATA box, no transcription occurs in nuclear 
extracts (Ryffel et al., 1989). If the HNF-1 binding site in the 
albumin promoter was methylated by bacterial Dam-methylase, its 
affinity for HNF-1 was lowered. Binding of HNF-1 to methylated HNF-i 
sites required cooperation of other trans-acting factors bound to 
adjacent upstream regions of the promoter (Tronche et al., 1989). 
HNF-1 is a member of a family of proteins which bind to the same 
consensus sequence (Rey-Campos et al., 1991). A factor with the same 
binding specificity as HNF-1 was identified in dedifferentiated 
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tepatoma cells. This factor is called vHNF-1 (Cereghini et al., 1988; 
Baumheuter et al., 1988; Rey-Campos et al., 1991) or LF-B3 (De-Simone 
et al., 1991) and can form heterodimers with HNF-1. Both HFJF-1 and 
vHNF1 are distant relatives of the homeodomain proteins which regulate 
changes in phenotype during development. 
To date, eight different cDNAs or genes corresponding to liver specific 
transcription factors have been cloned (Table 1.2). A number of other 
factors which are involved in liver specific regulation have been 
identified. These include SAP (Kugler et al., 1990) and HNF-5 (Grange 
et al., 1990). 
In general the liver specific transcription factors share homologies 
with previously recognised structural components of transcription 
factors. These include zinc fingers, homeodomains, leucine zippers, 
basic regions and the POt) domain (reviewed by Struhl, 1989). It is not 
known whether transcription factors with a particular structural domain 
have a particular role in gene regulation. For example factors with 
homeodomains may be important in development while factors with zinc, 
fingers may be important in hormonal induction. 
Zinc fingers are formed by the interaction of two pairs of cysteine 
residues or a pair of cysteine and a pair of histidine residues with 
a single zinc ion (reviewed by Evans and Hollenberg, 1988; Fairallet 
al., 1986; Rhodes and Klug, 1986). These interactions generate a 
configuration called a zinc finger which binds to the DNA in a sequence 
dependent manner. The nuclear hormone receptors are zinc finger 
proteins, and there are also many "orphan" receptors with no known 
ligands amongst which ar6 two liver transcription factors, Hepatocyte 
Nuclear Factor-4 (HNF-4) (Slade?k  et al., 1990) and Apolipoprotein Al 
Table I. i Liver specific transcription factors. 
Liver Factor 	Structure 	 Reference 
C/EBP 	 leucine zipper and 
	
Landschulz et al., 1988 
basic 	 Birkenmeier et al., 
I13! 
DBP 	 basic 
HNF-1 (LF-B1, homeodomain, POU A 
APF) 	 domain 
HNF-3A 	new type 
HNF-4 	 zinc-finger 
LAP 	 leucine zipper and 
basic 
Mueller et al., 1990 
Frain et al., 1989 
Lai et al., 1990 
Sladek et al., 1990 
Descoinbes et al., 1990 
ARP-1 	 zinc-finger 	 Ladias and Karantha-. 
nsis, 1991 
Regulatory Protein 1 (ARP-1) (Ladias and Karathanasis, 1991). Zinc 
finger proteins are able to form homo- and hetero-dimers (reviewed by 
Forman and Samuels, 1990) and some can also interact with leucine 
zipper proteins (Schule et al., 1990; Yang-Yen et al., 1990; Jonat et 
al., 1990). These interactions may be important for hormone responses. 
The homeodomain consists of a helix-turn-helix motif, two a-helices 
separated by a 0-turn (Laughon and Scott, 1984; Shepherd et al., 1984). 
The a-helices interact with a specific DNA sequence which is usually 
an inverted repeat suggesting that these proteins bind to DNA as 
dimers. Both homodimers and heterodimers can form and bind to DNA (Rey- 
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Campos et al., 1991). The hoineodontain proteins are expressed in 
different regions of the embryo during development (Manley and Levine, 
1985; Gehring, 1985). A distant relative (HNF-1) is found amongst the 
liver transcription factors (Frain et al., 1989). HNF-1 also contains 
• POU-A domain (Bauinheuter et al., 1990), a conserved domain found in 
• number of transcription factors which turn on gene expression during 
development (He et al., 1989; Herr and Sturm, 1988; Rosenfeld, 1991). 
The POU-domain itself is important for DNA binding but may also be 
involved in interaction with other transcription factors. 
Leucine zippers are coiled coil protein structures through which two 
polypeptides bind to each other. The dimer is able to bind to a 
specific DNA sequence (Landshulz et al., 1988). The region of the 
polypeptide which forms the coiled coil contains four or five leucine 
residues which are spaced at seven residue intervals. The DNA binding 
domain is in another part of the protein and is often basic but can be 
of other types (reviewed by Busch and Sassone-Corsi, 1990). Many 
leucine zipper proteins are activated in response to mitogens like 
polypeptide hormones (reviewed by Herschman, 1989). others are 
inactivated or modified in a similar way in response to unknown 
stimuli. In general, these proteins may be involved in mediating 
hormone responses. In the liver, two leucine zipper transcription 
factors have been identified, C/ESP (Landshulz et al., 1988) and Liver 
Activation Protein (LAP) (Descombes et al., 1990). These proteins may 
be members of a family of leucine zipper proteins which are activated 
in the liver at different times (Akira et al., 1990; Roman et al., 
1990). 
Liver specific transcription factors are also synthesized in other 
tissues, mRNA for four out of six of the cloned factors where tissue 
distribution has been examined, are found in kidney and intestine. mRNA 
10 
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for three out of six are found in lung, spleen and brain (references 
as table 1.5). Some genes which are expressed in the liver are also 
expressed in these other tissues. Their expression is controlled by the 
level of both transcription factors and inhibitors. The presence of 
mRNA for transcription factors does not always correlate with the 
presence of the active factor. Some of the transcription factors are 
regulated at levels other than transcription. 
HORMONAL REGULATION OF GENE EXPRESSION IN THE 
LIVER 
Much is known about the regulation of gene expression in the liver by 
several different types of hormone. Here the hormones are divided into 
two groups. The first group consists of hormones which can pass through 
the cell membrane and bind to intracellular or nuclear receptors. These 
receptors can bind directly to DNA to cause transcriptional activation 
(reviewed by Beato, 1989; Auricchio [TH, 1989; Beato et al., 1989; 
Gehring 1987; Evans, 1988; Forman and Samuels, 1990). The 
second group are polypeptide hormones which cannot enter the cell 
directly but which bind to membrane bound receptors. A number of 
intracellular pathways convey the signals from the receptor to 
intracellular and intranuclear factors (reviewed by Kahn, 1990; Ullrich 
and Schlessinger, 1990; Cosman et al., 1990). 
Both groups of hormones have "liver specific" effects on gene 
expression. In some cases liver specific transcription factors bind to 
regions of the DNA adjacent to the hormone response elements and 
interact with the hormone-activated transcription factors. Interactions 




In the liver many genes are subject to hormonal regulation. For 
example, many of the genes involved in carbohydrate metabolism are 
controlled by adrenal steroids and insulin (Jacobs and Cuatrecasas, 
1981; Kahrcr1981). Fat metabolising enzymes are controlled by adrenal 
steroids, thyroxine and insulin (Elshourbagy et al., 1985; Strobl et 
al., 1990; Apostolopoulos et al., 1988). Acute phase reactants are con-
trolled by adrenal steroids, interleukins and interferons (Baumann et 
al., 1989; Schreiber et al., 1989). Proteins involved in sexually 
dimorphic steroidogenesis and drug metabolism are regulated by GH and 
thyroxine (Porsch-Hallstrom et al., 1990; Zhao et al., 1990; Jansson 
et al., 1988; Johansson et al., 1989; Oscarsson et al., 1991; Shapiro 
et al., 1989; Norstedt and Palmiter, 1984). None of these responses is 
regulated exclusively by a single hormone and interactions between 
hormone-activated transcription factors is anticipated. The molecular 
details of some hormone stimulated effects on liver gene expression are 
described in the following sections. 
Nuclear Hormone Receptors 
Receptors for all of the diffusible hormones have now been cloned and 
they are members of a large superfamily of molecules. The family 
includes "orphan" receptors for which there is no known ligand (Ladias 
and Karanthansis, 1991). The receptor is able to bind specifically to 
the ligand and to a region of the DNA (the Hormone Response Element 
HRE). this binding activates or inhibits transcription. 
The sequences to which receptors bind have been "idealized" into two 
core motifs 6bp long either TGACCT (thyroxine, retinoic acid and 
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oestrogen) or TGTTCT (glucocorticoids). HREs normally contain a number 
of core motifs and the orientation and spacing of these motifs in the 
DNA determines the specificity of the HRE. Different combinations of 
core motifs can be assembled which mediate responses to different 
subsets of hormones (Naar et al., 1991; Umesono et al., 1991). The 
responses can be either positive or negative or a combination. For 
example two direct TCAGGTCA repeats separated by 3bp can confer a 
retinoic acid response whereas two inverted repeats of the same 
sequence separated by 3bp confer an oestrogen response. Two adjacent 
inverted repeats of the same sequence can confer a retinoic acid, 
thyroxine and vitamin A response (Naar et al., 1991; Umesono et al., 
1991). 
The DNA binding domain of the receptor polypeptides are cysteine rich 
and form two zinc fingers which recognize and bind to the HRE. Amino-
acids at three positions in the first zinc finger are important for 
discrimination between the core motifs and are referred to as the 
discriminatory amino-acids (reviewed by Forman and Samuels, 1990). Some 
receptors are very stringent in their recognition of core motifs. These 
include the oestrogen and glucocorticoid receptors which only recognise 
inverted repeats of their respective core sequences. Substituting the 
three discriminatory amino-acids of the glucocorticoid receptor for the 
three discriminatory amino-acids from the oestrogen receptor generates 
a mutant receptor which recognises a GRE but not an ERE (Mader et al., 
1989). 
Other receptors including the thyroxine and retinoic acid receptors can 
bind as dimers to both direct and inverted repeats of their preferred 
core sequence. The C-terminal region of these receptor proteins is 
important for dimerization and it may be a flexible region which can 
move around to allow dimerization irrespective of orientation, alterna- 
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tively, each receptor protein may have more than one dimerization face 
(Naar et al., 1991; Umesono et al., 1991). 
Ligand binding causes an alteration in the conformation of the 
receptor. This is important for many activities of the receptor 
polypeptides for example DNA binding, transact ivation, association with 
other proteins, dimerization and nuclear localization. The function of 
the receptor is affected not only by the concentrations of receptor and 
ligand but also by other proteins which may bind to the receptor, the 
HRE or the ligand. Other proteins can activate or inactivate the 
receptor and in this way modify the response in a cell-specific manner. 
In the liver the direct interaction of receptors with liver specific 
transcription factors have been demonstrated (Grange et al., 1990). In 
other cases liver specific transcription factors are necessary for 
transcription but may not interact directly with the receptor. 
Membrane Bound Receptors 
Membrane bound receptors for many polypeptide hormones have been 
- cloned. These are classified into several groups based on their 
structural homologies. The two major groups found in the liver are 
described here The first group S have an integral tyrosine kinase 
activity and include the EGF-R, Insulin-R, IGFI-R and PDCF-R (Ullrich 
and Schlessinger, 1990). The second group belong to the hematopoietin 
• receptor superfamily and include 1L6-R, IL1-R, GH-R and PRL-R (Cosman 
et 1990). Both families of receptors have an extracellular 
glycosylated ligand binding domain, .a single hydrophobic transmembrane 
• domain and an intracellular domain. Amongst the receptors with tyrosine 
kinase activity there are several structurally distinct types of 
extracellular domain. The tyrosine kinase component of the intracellu- 
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lar domain, however, is very highly conserved. The members of the 
hematopoietin receptor superfamily have no single recognised homology 
in the intracellular domain. The characteristic features of this family 
are two conserved pairs of cysteines and a Trp-Ser-X-Trp-Ser motif in 
the extracellular domain (Goodwin et al., 1990). 
In the cell membrane there are frequently two forms of a particular 
receptor with different affinities for the ligand (Gearing et al., 
1989; D'Andrea et al., 1989; Yamasaki et al., 1988; Wang et al., 1989). 
This difference in affinity is due to specific binding sites with two 
different binding affinities, as opposed to specific and non-specific 
sites. The number of high affinity sites is small compared with low 
affinity sites. The biological activity of the hormone is consistent 
with the high affinity sites being the active receptors (D'Andrea et 
al., 1989) which suggests that they are modified in some way to 
increase their affinity for the ligand. The modification of receptors 
is cell specific. When a receptor cDNA clone is expressed in different 
cell types, some produce both high and low affinity sites while others 
produce only low affinity sites (Gearing et al., 1989). changes in the 
affinity of receptors can be brought about by post-translational 
modifications such as glycosylation (Szecowka et al., 1990) or 
phosphorylation or in some cases by interaction with another protein 
(Hibi et al., 1990). 
Association of some receptors with proteins thought to be part of the 
secondary messenger pathway, such as GTpases (G proteins) and tyrosine 
kinases, increases their affinity for the ligand. The receptor domains 
responsible for this interaction have not been characterized. The G-
proteins, which are intracellular, associate with the cytoplasmic or 
transmembrane domain of the receptor. Tyrosine kinases may be intracel-
lular or membrane-bound proteins. Soluble versions of many membrane 
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receptors have been identified which can be formed from the membrane-
bound receptor by peptide cleavage or coded for by a separate RNA 
(Petch et al., 1990). A tyrosine kinase called GP130 can interact with 
both the membrane bound 1L6-R and the soluble 1L6-R. The soluble 
receptor lacks both the transmembrane and cytoplasmic domains which 
means that GP130 can interact with the extracellular domain (Hibi et 
al., 1990). The soluble 1L6-R can potentially interact with GP130 in 
a cell with no endogenous 1L6-R. 
Receptors act through secondary messenger pathways which have not been 
fully characterized for any receptor. There are several pathways which 
the same receptor may activate to differing extents (Kahn, 198; 
Ullrich and Schlessinger, 1990). In all pathways phosphorylation of 
proteins on tyrosine, serine or threonine residues plays a central 
role. There are a large number of protein kinases and phosphatases 
which are activated or inactivated by different receptors amongst which 
are four classes; tyrosine kinase, phospholipase, protein kinase C and 
cAMP dependent protein kinase. Tyrosine kinase phosphorylates tyrosine 
residues of a number of intracellular substrates and many receptors 
themselves have tyrosine kinase activity. Phospholipase C-gamma is 
activated by a tyrosine kinase. It can then hydrolyse inositol 
phospholipids to generate inositol tn-phosphates and diacylglycerol. 
Protein kinase C is activated by diacylglycerol and phosphorylates 
serine and threonine residues. cAMP dependent protein kinase is 
activated by cAMP generated from activation of adenylate cyclase by G-
proteins, cAMP dependent protein kinases phosphorylate proteins on 
serine residues. 
Each receptor, with or without an integral tyrosine kinase, activates 
a different subset of protein kinases to generate many different 
secondary messenger pathways using different subsets of the same basic 
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components. This ultimately leads to changes in protein activity and 
gene expression. As one would expect, some transcription factors are 
activated by phosphorylation. 
Transcription factors whose activity is altered by peptide hormones 
have been isolated from stimulated cells by their ability to bind 
regions of DNA known to mediate the hormonal response. The genes or 
cDNAs corresponding to some of these factors have been cloned. Some 
have been shown to interact with liver specific transcription factors 
(Slade .k et al., 1990; Akira et al., 1990) and some are phosphorylated 
in response to hormonal stimulation (Kessler et al., 1990; Imam et al., 
1990). To date, only a very small number of peptide hormone stimulated 
transcription factors have been identified. There is still a long way 
to go before the response to peptide hormones has been fully character-
ized. 
THE PRODUCTION OF GROWTH HORMONE AND THE CONTROL OF SEXUAL 
DIMORPHISM IN THE LIVER 
The following section contains a description of GH, its synthesis in 
somatotrophs and the timing and pattern of GM release. It also includes 
a discussion of the control of GM production and release by somatosta-
tin (SS), growth hormone releasing factor (GRF), the sex steroids, 
adrenal and thyroid hormones. The final section relates to regulation 
of sexual dimorphism in the liver by GH. 
GH Synthesis, The Timing and Pattern of GH Release 
GM genes and cDNAs from a number of species including human, rat, cow, 
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pig, chicken and horse have been cloned (Goeddel et al., 1979; Seeburg 
et al., 1977; Seeburg et al., 1983; Lamb et al., 1988; Miller et al., 
1980). GM is closely related to prolactin (PRL). The genes for these 
two hormones probably arose by gene duplication and divergence. hGM can 
cross react with both the rGM and rPRL receptors (Merington et al., 
1983) and it is important to distinguish between the lactogenic and 
somatogenic properties of GM when it is administered across species. 
Both PRL and GH are made in the pituitary gland. During development 
stem- somatotrophs are the common precursor to both the GM-producing 
somatotroph and PRL-producing lactotroph populations (Behringer et al.., 
1988; Borrelli et al., 1989). Transcription of both PRL and GH is 
activated by a pituitary specific transcription factor pit-1 also 
called GMl. Other factors confine transcription of each hormone to its 
respective cell type during development (Simmons et al., 1990; Fox et 
al., 1990; Crenshaw et al., 1989). 
Plasma GM levels begin to increase in rats during the late fetal period 
then decline after birth. GM levels increase again before puberty and 
decrease in old age (Eden 1979; Sonn:tag et al., 1980). The 
levels of GM in the plasma of pubertal and adult rats vary episodically 
in a sexually dimorphic manner. Male rats have a very low or undetect-
able basal level of GM in the plasma which rises during regular spikes 
of GM release every 3 to 3.5 hours. Female rats have a high basal level 
of GM with frequent irregular spikes of GH release which are lower than 
those found in males and are slightly elevated during the night 
(Millard et al., 1986; Saunders et al., 1976). 
Plasma levels of GM also vary in humans. The variation during 
development is similar to that in rats, however, in adult humans GM 
secretion is oscillatory rather than episodic. In both sexes GM pulses 
occur with an average frequency of 13 per day. In contrast to rats, 
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both the pulse amplitude and the basal secretion is higher in females 
(Winer et al., 1990). 
Control of Gil Synthesis and Release by Thyroxine, Adrenal 
and Sex Steroids, Somatostatin (SS) and Growth Hormone 
Releasing Factor (GRE). 
In gonadectomized rats the sexually dimorphic pattern of GM release is 
lost. Administration of androgens to gonadectomized males or adult 
females causes a masculinization of GM release by lowering basal GM 
secretion and increasing spike height (Ja nsson and Frohman, 1987). 
Administration of estradiol to gonadectomized female mice or adult 
males caused a feminization of GM release by increasing basal Gil levels 
and GM pulse frequency and decreasing pulse amplitudes. 
Partial masculinization of the GM pattern was retained if male 
rats were gonadectomized during puberty. This indicates that neonatal 
androgens could partially imprint a male pattern of GM secretion on 
adults (Jansson et al., 1985; Ja:nsson and Frohman, 1987). Both 
adrenalectomy and thyroidectomy of rats resulted in reduction in the 
level of GM release which was restored by administration of glucocorti-
coids or thyroxine respectively (Spindler et al., 19$z). 
The sex steroids and glucocorticoids influence both the release and 
synthesis of GM (Frohman et al., 1987; Eden et al., 1987; vale et al., 
1983; Hertz et al., 1989). The effect of the sex steroids on Gil release 
and synthesis is partially indirect and mediated by two hypothalamic 
peptides, GRE and SS, which act antagonistically to regulate GM 
production and release. These two peptides are discussed further below. 
The sex steroids also act directly on the pituitary. Androgens increase 
the response to GRE and SS while oestrogens decrease the response (Eden 
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et al., 1987; Webb et al., 1983; Simard et al., 1986; Wehrenberg et 
al., 1985; Fukata and Martin, 1986; Evans et al., 1985). 
The transcription of both rGB and hGH are influenced by a number of 
hormones which interact at various levels. Glucocorticoids increase 
transcription of both rGH and hGH. Thyroxine increases the transcrip-
tion of rGH and bGH but not hGB (Brent et al.,, 1988). GRF increases 
transcription of all GHs. The mechanism of hormone action upon GH 
transcription is complex. Both glucocorticoids and thyroxine along with 
retinoic acid have a direct receptor mediated effect on rGB transcrip-
tion. The effect of GRF on transcription is mediated by cAMP which may 
act by altering the binding of pituitary specific transcription factors 
to the rGB promoter. The many hormones act synergistically on GB 
transcription (Bedo et al., 1989; Copp and Samuels, 1989; Dana and 
Karin, 1989). 
The sex steroids regulate the production of GRF and SS by an unknown 
mechanism. GRF is a 40 to 44 amino-acid peptide and 55 is a 14 amino-
acid peptide (Brazeau et al., 1973; Rivier et al., 1982). GRF promotes 
GB synthesis and release and is a mitogen for somatotrophs (Vale et 
al., 1983; Billestrup et al., 1986; Billestrup et al., 1987). SS 
inhibits the action of GRF. In male rats SS tone is high during the low 
basal release of GB (Clark and Robinson, 1987). When SS tone is high 
GRF administration does not lead to GB release (Clark and Robinson, 
1987). SS inhibits GB release but allows some GH synthesis to occur. 
GB accumulates and in male rats is released in spikes in response to 
SS withdrawal and GRF pulses. 55 and GRF levels are lower and more 
constant in female rats. GRF administration leads to GH release at any 
time but the response is lower than male spikes of GB release (Clark 
and Robinson, 1985$. The effect of sex steroids on GM release can be 
mimicked by administering 55 and GRF to imitate that of either a male 
411 
or a female (Clark and Robinson, 1987). 
The Regulation of Sexual Dimorphism In The Liver By GH 
In the liver many proteins which are regulated by GM are also sexually 
dimorphic (Table I.3A and B) and like the pattern of GH in the plasma, 
the pattern of gene expression of these GM responsive proteins changes 
during puberty. This indicates that the pulsatile male or the more 
continuous female patterns of plasma GH alter gene expression in the 
liver. Both patterns of plasma GM have both inhibitory and inductive 
effects on different substrates. Particular examples of proteins 
regulated in different ways by GM can be found in the Cytochrome P450 
gene family. IIC11 and 11C12 are not expressed in the immature rat and 
at puberty expression of IIC1 1 is induced by the male pattern of plasma 
GM while the female pattern has no effect (Morgan et al., 1985). In 
direct contrast to this 11C12 is induced at puberty by the female 
pattern of plasma GM while the male pattern has no effect (Guzelian et 
al., 1988). 11C13 and 111A2 on the other hand are expressed in the 
immature rat. At puberty expression is suppressed by both patterns of 
plasma GM but more by the female pattern than the male pattern 
(McClellan-Green et al., 1989; Waxman et al., 19890. 
Other hormones such as insulin, thyroxine and glucocorticoids can 
enhance or repress expression of GM responsive genes in the liver 
(Tollet et al., 1990; Mode et al., 1989; Waxman et al., 1990; Shimada 
et al., 1989; Keller ane'to'toç, 1979). Part of the action of these 
hormones may be mediated by their effect on GM expression as mentioned 
above but in addition, direct effects of these hormones have been 
observed on GM responsive genes in isolated hepatocytes (Tollet et al., 
1990; Gu4ian et al., 1988). At least part of this effect is due to the 
action of thyroxine, glucocorticoids and insulin on elements of the GM 
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signalling pathway, for example on"he- GH receptor (Toilet et al., 
1990; Mimi et a]., 1990). 
Table I. 3A Sexually dimorphic gene expression in the liver 
Genes expressed at higher levels in male liver 
mouse 	 rat 
Sex limited Heinnienway and Rob- NA 
protein ins, 	1987 
EGF-R Jansson et a]., 	1988 Johansson et al., 
1989 
MUP, a2- g- Finlayson et a]., Roy and Neuhaus, 
lobulin 1963 1966 
P450 IIC11 NA Guzelian et al., 
1988 
P450 11C13 NA McClellan-Green et 
al., 	1989 
P450 11A2 NA Waxman et a]., 	1989b 
P450 111A2 NA Shimada et a]., 	1989 
3 0 -HSD NA 40 et al., 	1990 
C-P450 1 , Noshiro and Megishi, 
- 1986 
c-myc NA Porsch-Hallstx'om et 
al., 	1990 
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Table I. 3B Sexually dimorphic gene expression in the liver 
Genes expressed at higher levels in female liver 
mouse 	 rat 
P450 11C12 	 NA 	 Mode et al., 1989 
I-P450 15 	 Noshiro and Negis- NA 
hi, 1986 
PRL-R 	 Norstedt and Palm- Robertson et al., 
iter, 1984 	 1990 
Apolipoprotein E 	MA 	 Oscartn et al., 
1991 
GH receptor cDNAs have been cloned from rabbit, rat and mouse (Leung 
et al., 1987; Mathews at al., 1989; Smith et al., 1989). The nucleic 
acid sequences of the receptors from different species share approxi-
mately 70% homology. The GH-Rs are homologous to other growth factor 
receptors and are members of the hematopoietic receptor gene superf am-
ily (reviewed by Cosman et al., 1990). The same or closely related GH-
Rs are expressed in many cell types (Tiong and Herington, 1991) and 
expression is not sexually dimorphic in the liver (Herington et al., 
1983). 
Several different sizes of receptor RNA and protein are found (Smith 
et al., 1987; Spencer et al., 1988). In rats and mice two of these are 
due to alternative patterns of splicing of the GH-R pre-mENA at the 
exon 7 to 8 junction (Smith et.al., 1989; Baumbach et al., 1989). The 
two sizes of mRNA produced in this way code for two proteins with the 
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same N-terminus. The longer protein (GH-R) has three domains, an 
extracellular ligand binding domain, a hydrophobic trans-membrane 
domain and a cytoplasmic domain. The shorter protein (GH-BP) has the 
same extracellular domain but has a substituted transmembrane domain 
and lacks the cytoplasmic domain (Mathews et al., 1989; Baumbach et 
al., 1989; Smith et al., 1989). The role of the GH-BP is not known. 
The extracellular domain is highly glycosylated which increases its 
affinity for GM (Szecowa et al., 1990; Leung et al., 1987). The 
intracellular domain has no homology to tyrosine kinase or any other 
signalling molecules (Mathews et al., 1989; Leung et a.!., 1987) however 
highly purified GH-Rs exhibit tyrosine kinase activity (Carter-Su et 
al., 1989). Tyrosine-kinase associated GH-R is closely related to the 
cloned GH-R and may either be identical or a receptor isoform which has 
not been cloned (Stubbart et al., 1991). 
Following GH binding the GH-Rs are rapidly internalized. In male rats 
this results in a depletion of GH-R from the membrane shortly after GM 
pulses (Bick et al., 1989). Both GM and the GH-R are rapidly processed 
and destroyed and replacement of GM-R on the membrane probably requires 
de novo synthesis (Baxter 1985). It is not clear whether the 
GM receptor plays an active part in the reaction cascade or serves only 
to internalize the ligand. 
Further studies are required in order to understand the response to the 
male and female patterns of plasma GM at the membrane. At present it 
is known that an interpulse interval of at least 2.5 hours is an 
essential component if the plasma profile is to be recognised as the 
male pattern. Neither the peak height nor width are important. After 
a pulse of GH the hepatocytes become refractory to further pulses for 
2 to 2.5 hours and this can occur even with low pulses probably because 
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of the high affinity of the GM-R for GH (Leung et al;, 1987). :This 
would be consistent with a model in which the interpulse interval is 
the time required for de nova synthesis of GH-Rs and their insertion 
into the membrane. 
Further studies are also required to characterize the intracellular 
signals and molecular changes that lead to the two different patterns 
of gene expression in males and females. At present it is known that 
the stimulation of IGF-I transcription by GH occurs to the same extent 
in males and females (Maiter et al., 1988) and that IGF-I mRNA 
increases within hours of GM stimulation (Toliet et al., 1990; Johnson 
et al., 1989), in the absence of protein synthesis (Toilet et al., 
1990). In contrast transcription of P450 and MUP are sexually dimorphic 
(Mode et al., 1959; Derman, 1981), it can take several days for GM to 
induce p450 mRNA (Noshiro and Negishi, 1986) and the induction requires 
protein synthesis (Toilet et al., 1990). 
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THE MOUSE MAJOR URINARY PROTEINS (MUPS) 
Although a function has not been ascribed to MUPs and the closely 
related rat a2 -globulins, they are probably involved in the transport 
of a small molecule (Held et al., 1987). The expression of MUPs and 
a2 -globulins are limited to tissues involved in secretion. Both are 
expressed in liver and the lachrymal, salivary, sebaceous glands, a 2 -
globulin is also expressed in the preputial glands (Kuhn et a.Z.,1984, 
Held et al., 1989). High levels of MUP and a 2 -globulin are excreted in 
the urine and a2 -globulin is found in saliva (Laperche et al., 1983). 
MUPs and a 2 -globulin belong to a superfamily of proteins whose 
function is to transport small hydrophobic molecules like retinol 
(vitamin A), odorants and branch chain fatty acids. Members of the 
protein superfamily are characteristically small (160 to 180 amino-
acids long), acidic and acid stable proteins. The ligand binding site 
is at the centre of a 13-barrel and contains the hydrophobic residues 
tryptophan and phenylalanine. Members of the protein superfamily are 
commonly filtered out in the glomeruli and found in urine, particularly 
after tubule damage. Non-physiological binding of a 2 -globulins to two 
small synthetic hydrophobic molecules (d-limonene and 2,2,4-trimethyl 
pentane) found in petrol prevents degradation of a 2 -globulin in the 
nephrons and leads to kidney necrosis (Lehman-McKeeman et al., 1989; 
Swenberg et al., 1989). 
The MUP proteins are 162 amino-acids long with an 18 to 22 amino-acid 
signal peptide. a2 -globulins are 162 amino acids long with a 19 amino 
acid signal peptide. Laboratory mouse or rat strains secrete eight to 
twelve different MUPs or ;-globulins respectively in their urine 
which are heterogeneous in charge. The proteins are coded by different 
genes and single amino-acid differences lead to products distinguish-
able by narrow range isoelectric focusing (IEF). In addition to the 
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different charged MUP proteins then are at least three different sizes 
of MIJPs distinguished by SDS PAGE. The higher molecular weight MUPs are 
variants which have an n-linked glycosylation site which is also 
present in a 2 -globulins at amino acid 35 (Uterman et al., 1981). The 
structure of the lowest molecular weight MUPs is not known. It is also 
not known why there are so many different MUP and a 2 -globulin pro-
teins. One could hypothesize that they are necessary to bind different 
1 i gands. 
MUPs and a2 -globulins form very large, closely related gene families. 
There are 30 to 35 MU? genes all located on chromosome 4 at a genetic 
locus called Mup-? (Hastie et al.,1979, Bishop et al.,1982, Krauter et 
al.,1982, Bennettet al.,1982, Shi et al.,1989). Similarly, there are 
20 - 25 rat a 2 -globulin genes at the Mup-1 locus on rat chromosome 5 
(Kurtz, 1981). The MUP genes are arranged in head to head pairs, 
forming large imperfect palindromes (Bishop et al., 1985, Ghazal et 
al., 1985). These are tandemly arranged but their relative orientations 
are not known (Bishop et al.,1985). The arrangement of the MUP genes 
may explain their number. Large inverted repeats in DNA are often 
associated with the tandem amplification of genes under selective 
pressure and similar mechanisms may underlie amplification in normal 
cells (Ford and Fried, 1986). 
The total size of the MUP palindrome is 45kb, with a central unique 
region of 6kb and 5kb of 5' sequence, 3.5kb of coding region and 11kb 
of 3' sequence duplicated in divergent orientations on either side 
(Bishop et al., 1985, Ghazal et al.,1985). Two groups of MUP genes, 
group 1 and group 2 were defined by sequence homology and each palin-
dromes contains a group 1 and a group 2 gene. All of the group 1 genes 
which have been isolated appear to be functional whereas the group 2 
genes are pseudogenes with a conserved stop codon at amino-acid 7 in 
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the reading frame used by group 1 genes. A number of pseudogenes were 
found amongst a2 -globulin genomic clones suggesting that a 2 -globulin 
genes may have the same organisation as MUPs (Winderickx et al., 1987). 
Genes within group 1 or group 2 are very similar to each other, based 
on the coding region sequences (1 to 2% difference between group 1. 
genes) (Ghazal et al., 1985). Between the groups there is adifference 
of 11 to 15% spread equally over the introns and exons. This suggests 
that the group 2 genes arose as a duplication of a pseudogene allowing 
equal divergence of the coding and non-coding region (Clark et al., 
1985). Both groups have diverged equally from a 2 -globulin and appear 
to have undergone concerted evolution. The group 1 genes have more 
silent base substitutions relative to ;-globulin suggesting conserva-
tion of protein function by selection. 
There are approximately 24 MU? genes which are members of groups I or 
2. The other 6 to 11 genes are members of groups 3 or 4 (Al-Shawi et 
al., 1989). They are also found near the Mup-1 locus but may not be 
arranged in 45kb palindromes (Shi et al., 1989). Two group 3 and three 
group 4 genes have been identified (Ma 1987; Shahan et al:, 1987b). 
Groups 3 and 4 are more closely related to each other than to groups 
1 or 2. Group 3 genes are further distinguished because they code for 
the glycosylated MUPs (Kuhn et al., 1984; Ma 1987). Groups 3.and 4. 
differ from the group I genes in 15% of nucleotides in the coding 
region (Kuhn et al., 1984, Ma, 1987) and 22% of amino-acids. A similar 
subgroup of approximately six a 2 ,-globulin genes differ from the others 
by 5% of nucleotides clustered in exon 3 (13% difference) (Laperche et 
al., 1983; Gao et a.!., 1989). 
Although the 35 MUP genes are highly homologous one region shows large 
variation. This is approximately 50 nucleotides upstream of the cap 
site, where there is a stretch of adenine residues or adenine 
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interspersed with cytosine which varies in length from 65 nt (group 1 
gene, BSI) to 13nt (group 1 gene, BL6-51) Al-Shawi et al., 1989; Held 
et al., 1987. The a 2 -globulin genes have a similar hypervariable 
region in the same position. 
EXPRESSION OF MOP AND cx2 -GLOBULIN 
Splicing 
MIJP genes have seven exons and number of different patterns of splicing 
occur. Two major sizes of MUP mRNA (0.77 and 0.9kb) detected in the 
liver are produced by different splicing in the 3' non-coding region. 
The long message contains a short version of exon 6 called exon 6a and 
exon 7. The short message contains a long version of exon 6 and no exon 
7. A second type of long mRNA contains an extra thirty-one nucleotides 
from the 5' end of intron 6 before the splice with exon 7 (Shahan et 
al., 1987a, Chave-cox 1986). The rat liver a 2 ,-globulins are spliced 
like the long mRuAwithout the extra thirty-one nucleotides. Several 
different ;-globulin mRNAs are present in the rat submaxillary gland. 
They are made from two different genes using a combination of six 
different splice acceptor sites in exon 6, intron 6 and exon 7 and two 
different polyadenylation signals. None of the splice acceptor sites 
is the same as that used by liver a 20-globulin mRNAs (Gao et al., 
1989). The reason for the different patterns of splicing and their 
effects on mRNA stability are not known. In some cases sequences 
present in introns have been shown to be important for mENA stability 
and translational efficiency it is not known whether any important 
sequences are present in intron 6 of MUPs or a2 -globulins. 
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Pseudogenes 
The group 2 pseudogenes are either not expressed or expressed at very 
low levels. There are several features of the group 2 genes which would 
be detrimental to expression (Clark et al., 1985) and no group 2 RNA 
was detected in liver by hybridization of group 2 specific oligonucleo-
tides (Shahan et al., 1987a; McIntosh and Bishop 1989). Whittaker 
(1989) showed that in transgenic mice the group 2 promoter was able to 
direct a very low level of expression of the Herpes Simplex virus 
thymidine kinase reporter in the liver (5% of group 1 promoter). 
Functional genes 
Tissue-specificity 
Members of the four groups of MUP genes defined by sequence homologies 
also have similar patterns of expression. Many group 1 MUPs are 
expressed in the liver and a subset of group 1 MUPs are expressed in 
the mammary gland and perhaps the sebaceous glands (Held et al., 1989). 
Group 3 MUPs are expressed in the liver. Different closely related 
subsets of the group 4 MUPs are expressed in the submaxillary gland 
(Hastie et al., 1979), lachrymal gland, parotid gland and sublingual 
gland (Shaw et al., 1983; Shahan et al., 1987a). In addition in each 
tissue the level, timing and hormonal regulation of expression is 
different. The expression of ;-globulins is similar to MUPs in that 
subsets of a2-globulins are expressed in liver, submaxillary (Antakly 
et al., 1982, Laperche et al., 1983, Gubits et al., 1984) and lachrymal 
glands (Gubits et al., 1984). However in contrast to MUPs, all of the 
;-globulin genes are expressed in the preputial and mammary glands 
(Held and Gallagher, 1985). 
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The level of MU! mRNA in each tissue varies. The liver is the site if 
highest expression where MUP makes up 5% of the mRNA. The liver is also 
an important site of a 2 -globulin expression, however the highest 
levels of a2 -globulin mRNA are found in the preputial gland. The 
levels of MUP and a2 -globulin inRNA in other tissues is much lower than 
the liver ranging from 0.21% of total mRNA in the submaxillary gland 
to 0.02% of total mRNA in the sublingual gland (Shaw et al., 1983). 
Silent genes 
Not all of the functional MUP genes are expressed. Two group 4 MUP 
genes, Mup-1.5a and Mup-1.5b, are each present in one copy in the 
genome of the inbred mouse strain Balb/cByJ (Shi et al., 1989). Both 
genes are capable of making mRNA but !'fup-1.5b is silent. The two genes 
are very closely related and differ by three nucleotides out of 5kb 
including 500 bases of 5' and 3' region and 4kb of transcription unit. 
In the two inbred mouse strains Balb/c and C57BL/6 there are approxi-
mately twelve group 1 MUP genes but only six major group 1 proteins are 
made in the liver (Shaw et al., 1983, Clissold et al., 1984; Kuhn et 
al., 1984). This means either that at least one protein is coded for 
by more than one gene or that up to half the group 1 genes are silent. 
In two cases two group 1 genes were found to code for the same protein 
(Held et al., 1987), however in Balb/cJPt null mice deletion of 
approximately half of the group 1 genes has led to the loss almost all 
group 1 expression in the liver. This is consistent with half of the 
group 1 genes being comparatively silent (Shi et al., 1989, Duncan et 
al., 1988). Also consistent with this is the fact that only six 
different group 1 MUP cDNA clones have been described, five from Balb/c 
and one from C57BL/6 (Kuhn et al., 1984; Shahan et al., 1987b; Chave- 
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Cox, 1986). Further studies may lead to the discovery of silent group 
1 genes similar to the silent mupl.5b gene. 
Timing of expression 
The timing of expression varies between different MUP and a 2 -globulin 
genes. Expression of MUP in the submaxillary gland begins at approx-
imately one week of age, reaches maximum expression at three weeks of 
age and drops again in adults (Shaw et al., 1983). a 2 -globulins show 
a similar pattern of expression to MUPs in the submaxillary gland. 
Expression of a 20-globulin begins at ten days, reaches a maximum at 
thirty five days and decreases in the adult (McInnes et al., 1986). 
Expression of the lachrymal MUP gene is equal in young and adult mice 
(Shaw et al., 1983). a2 -globulin expression is different to that of 
MUP in the lachrymal gland. It begins at 15 days and increases to a 
maximum in the adult (McInnes et al., 1986). In the mammary gland, MUP 
is expressed during pregnancy and stops at parturition (Shaw et a]., 
1983). 
The onset of MUP expression in the liver coincides with the onset of 
sexual maturity. It begins at about 3 weeks after birth and increases 
to reach the adult level at 6 to 7 weeks (Barth et a]., 1982). a2 -
globulin expression also begins at the onset of sexual maturity. 
Transcription begins at 25 to 44 days after birth (Kulkarni et a]., 
1985). Expression of MUP and a 20-globulin in the liver is reduced in 
old rats and mice. This is associated with a loss of matrix association 




In some tissues the expression of MUP is sexually dimorphic. The degree 
of sexual dimorphism varies in different mouse strains and species. 
Most studies have utilized the Balb/c and C57BL/6 inbred strains, and 
the following discussion relates to these strains. 
The expression of the submaxillary MU? genes (Mup-1.5a and Mup-1.5b 
(Shi et al., 1989) is not sexually dimorphic and they are expressed 
equally in males and females in both the submaxillary and the 
sublingual glands (Shahan et al., 1987a). The lachrymal MU? gene (Mup-
1.4) is expressed five times more highly in male than female C57BL/6 
mice at the mRNA level and is induced by testosterone in hypophy- 
- sectomised mice or normal female mice (Shaw et al., 1983). The 
expression of a20-globulin in the lachrymal gland is also sexually 
dimorphic with a male to female mRNA ratio of three to one (Cubits et 
al., 1984). The level of expression of a 2 -globulin in the preputial 
gland is not sexually dimorphic. 
Expression of both MU? and a 2 -globulin in the liver is sexually dimor-
phic. In C57BL/6 mice the mRNA level in females is approximately one 
fifth of that in males. Expression of a 2 -globulin is high in male rats 
whereas in female rats it is barely detectable (Kulkarni et al., 1985). 
The loss of MUP or a 20-globulin expression in a number of hormonally 
deficient mice as shown in Table 1.4 implies that the expression of MU? 
and a2 -globulin is dependent on steroids, thyroxine, insulin and GH. 
Some hormones can affect the action of other hormones and it is often 
difficult to distinguish between a direct effect of the hormone or an 
indirect effect through another hormone. For example, thyroxine and 
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Table 1.4 Expression of MUP and a 2,-globulins in hormonally 
deficient mice and rats 
% ADULT MALES 
MICE RATS 
ADULT FEMALES 20 0 
TFM MALES (NO ANDROGEN 3 NA 
RECEPTOR) 
CASTRATED MALES NO 15 
THYROIDECTOMIZED MALES (No 2 NO 
THYROXINE) 
HYPOTHYROID MALE NA 10 
lit/lit MALES (LOW GM) 0.7 NA 
HYPOPHYSECTOMIZED MALES 0.2 0 
(NO PITUITARY HORMONES) 
ADRENALECTOMIZED MALES (NO 	NO 	23 
GLUCOCORTICOIDS) 
DIABETIC MALES (NO INSU- 	NA 	20 
LIN) 
NA - Not applicable NO - Not determined 
glucocorticoids enhance GM gene expression, synthesis and release 
(Martinoli and Pelletier 1989). Thyroxine also enhances GH receptor 
expression in the liver (Hochberg et al., 1990) and insulin affects the 
level of thyroxine and GM receptors in the liver (Murty et al., 1986). 
Recent studies have been directed at determining which hormone has a 
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direct effect on MUP and a2 -globulin expression. 
Some hormonally deficient rats and mice result from genetic lesions. 
Hormonal deficiency can also be induced by surgical, chemical or (more 
recently) transgenic ablation (Borrelli et al., 1989, Behringer et al., 
1988). Administration of hormones to hormonally deficient mice or rats 
which lack MUP or a2 -globulin expression can restore MU? or 
globulin mRNA levels. Sometimes expression can be induced by adminis-
tration of a hormone other than the one missing due to the primary 
lesion. In this way the hormone which has the most immediate effect can 
be identified. 
The following experiments show that androgens can be fully replaced by 
a combination of GB and thyroxine. 100% expression is taken as the 
normal MU? mRNA levels in liver. Testicular feminized mice are genetic 
males with a lesion in the androgen receptor which are therefore unable 
to respond to androgens making them phenotypically female. Administra-
tion of a combination of GM and thyroxine can completely replace the 
need for androgens to achieve 100% MU? expression in the liver (Knopf 
et al., 1983). On the other hand if hypophysectomized female mice which 
lack all the pituitary hormones including GM and TSH are given testos-
terone they do not show increased MUP expression over basal level or 
that induced by a combination of GB and thyroxine (Knopf et al., 1983). 
Therefore androgens cannot act to increase MUP expression in the 
absence of a functional hypopituitary system, whereas GM and thyroxine 
can. Thyroidectomized female mice given testosterone show 20% MU? 
expression whereas intact female mice given testosterone show 100% 
expression (Clissold et al., 1984) which indicates that as well as a 
functional hypopituitary system, thyroxine is required for the response 
to androgens. These results show that after thyroidectomy, hypophy.-
sectomy or in mice with androgen receptor deficiencies, androgens 
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cannot restore MUP mRNA levels whereas .a combination of GB and 
thyroxine can. 
It is thought that Gil is responsible for the sexual dimorphism of MIJP 
expression. Plasma Gil levels are sexually dimorphic as discussed 
previously. Female mice have a high basal level which is composed of 
a series of small but frequent peaks. Males have a low basal level 
which is almost undetectable, and spikes of Gil every 3 to 3.5 hours. 
GM can be administered to mimic one or other of these patterns. Injec-
tion of Gil every 12 hours is thought to imitate the male pattern and 
infusion of Gil by minipump is thought to imitate the female pattern. 
Gil administered by injection is more effective at inducing MUP mRNA 
than GM administered by infusion. Lit/lit mice are mutant dwarf mice 
which lack Gil but are able to respond to exogenous Gil administration. 
Lit/lit mice given Gil injections had 100% MUP expression. Those given 
infusions had 30%, which is near to the female level of MUP expression. 
This indicates that the pattern of plasma Gil can influence the sexual 
dimorphism of MU? expression (Norstedt and Palmiter, 1984). 
The interactions between GM and thyroxine administered to hormone 
deficient rats and mice are described in table 1.5. (Knopf et al., 
1983, Lynch et al., 1982, Murty et al., 1986). These results show that 
neither Ga nor thyroxine alone can fully induce MUP or a 2 -globulin 
mRNA. In thyroidectomized mice both thyroxine and GM levels are 
depleted because thyroxine is important for Gil transcription as 
discussed. Some effects of thyroxine on MUP and ;-globulin expression 
are due its effect on the GM gene but the inability of GB administra-
tion to induce MUP expression in the absence of thyroxine indicates 
that thyroxine is not only acting in this way but also affects the 
expression of MUP and a 2 -globulin more directly. It has been suggested 
that thyroxine affects the production of bound rather than unbound 
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ribosomes (Chatterjee et al., 1983) and therefore favors the production 
of secreted rather than non secreted proteins in the liver. 
A further complication of MOP expression in the liver is that different 
MOP genes respond to different extents to each hormone. Hormones could 
in principle change the level of MOP mRNA in the liver in either of two 
ways; by changing the transcription of all MOP genes equally or by 
specifically changing the transcription of one MOP gene. The actual 
situation is probably intermediate between the two extremes. Each 
hormone has some effect on all MOP genes but has a greater effect on 
one or more specific MOP genes. In the experiments referred to above 
the levels of urinary MOP and liver MOP mRNA were measured but 
individual MOPs were not examined. This may give a distorted view of 
the effect of hormones on MOP expression. Seven MOPs are produced in 
the liver of male C57BL/6 mice. The major protein products of group 1 
genes are designated MOPs 1 to 5 (Knopf et al., 1983), group 3 MOPs are 
designated MOP 6 and the origin of MOP 7 is not known. MOPs 2, 3 and 
4 are present in higher levels than 1, 5, 6 and 7. In female C57BL/6 
mice the major protein product is MOP 3. In thyroidectomized female 
mice given thyroxine, the levels of MOPs 1 and 5 were abnormally 
elevated. When thyroidectomized female mice were given testosterone the 
level of MOP 6 was elevated. When they were given CR by injection, MOP 
3 was elevated to produce a pattern of expression which is similar to 
that of normal female mice (Knopf et al., 1983). This suggests that 
lack of thyroxine prevents the induction of the male pattern of gene 
expression by injection of CR. 
The group 3 MOPs, in the liver, are regulated differently by hormones 
to the group 1 MOPs. The group 3 MOPs are relatively insensitive to 
thyroxine and show a smaller response to CR than group 1 MOPs (Kuhn et 
al., 1984). Studying individual genes in the liver allows differences 
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Table 1.5 The effect of Gil and thyroxine administration on 
xup and cr.-globulin expression in hormonally deficient 
mice and rats 
MICE RATS 
(% ADULT MALES) (% ADULT MALES) 
HPX FEMALE 	 0.2 	HPX MALE 	 0 
HPX+bGI-f 30 HPX+bGH (1 	8 
injection) 
HPX +THYROXINE 30 HPX + bGH (12 	78 
injections) 
HPX +THYROXINE 300 HPX + THYROXINE + 	4 
+bGH GLUCOCORTICOIDS 
MICE RATS 
(% ADULT MALES) (% ADULT MALES) 
THYROIDECTOMIZED 	2 	HYPOTHYROID 	10 
FEMALE (THX) 	 (HPT) 
THX+bGH 	 8 	HPT+bGH 	 89 
THX + THYROXINE 	60 	HPT + THYROXINE 	94 
THYROID ABLATED 	0 
FEMALE (TA) 
TA+bGH 	 0 
TA + THYROXINE . 	100 
in their hormone response to be analysed. The MUP genes are so highly 
homologous that the sequence changes which mediate different hormonal 
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regulation should be easily identified. Studies of other groups of 
closely related genes have yielded information about sequences involved 
in gene regulation. For example the DNA sequences of the a 1 antitrypsin 
genes of two mouse species differ by only 4% of nucleotides but they 
show quite different usage of enhancers and promoters to drive 
transcription (Latimer et al., 1990). Again, in the kallikrein genes 
single or double nucleotide differences in the regulatory elements are 
responsible for differences in the tissue specificity of expression 
(Wines et al., 1989). 
Genetic regulation 
The genetic environment is known to influence the regulation of MtJP 
expression. Previous studies have revealed variability in MUP patterns 
in different strains of mice (Szoka and Paigen 1979). Duncan et al., 
(1988) analysed two Balb/c substrains with different urinary MUP 
patterns and observed two modulator loci. One was tightly linked to the 
MUP locus and the other segregated independently. Balb/cJPt MUP null 
mice had very low levels of group 1 proteins in thefr urine. The 
phenotype was linked to a variant Mup-? locus in which approximately 
half of the group 1 genes had been deleted (Shi et al., 1989). The 
second phenotypic effect was due to a trans-acting modulator. The 
Balb/c substrain called Balb/cJPt MUP 4•1bo showed reduced expression 
of a single group 1 protein (MUP 4.1). The expression of MUP 4.1 in 
these mice was highly variable whereas the overall level of MUP 
expression was not affected. The trans-acting modulator is probably 
located on chromosome 15. 
Other variation in MUP proteins in urine was observed in recombinant 
inbred (RI) strains between C573L/6 and DBA/23. Some of these RI 
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strains showed a new MUP phenotype involving reduced expression of one 
group 1 protein called MUP 2.1. This was mediated in trans, but the 
genetic locus responsible for the effect was not located (Ma, 1987). 
Interesting observations relating to MUP function were made by Sampsell 
and Held (1985) who analysed MUP expression in a number of wild derived 
mice species. Expression occurred in the male liver in all species but 
expression in the female liver varied from none at all to equality with 
the male. In one case variation in expression was shown to act in cis 
because MUP genes retained their high or low levels of expression in 
female F 1 hybrid mice. The relative expression of group 1 and group 3 
like genes in the livers varied from species to species. In inbred mice 
90% of liver MUP mRNA is group 1 and 10% is group 3. In some wild 
derived species almost all mRNA was group 1-like whereas others had a 
high proportion of group 3-like mRNA. Similarly, some species had more 
group 3-like genes and some had more group 1-like genes. Not all 
species had the very large numbers of MUP genes observed in inbred 
strains. These results shos.i that features of MUPs in inbred strains, 
such as a large number of genes, sexual dimorphism of liver expression 
and a high level of group 1 expression are by no means universal 
amongst wild mouse species. 
Intrastrain variation was described by McIntosh and Bishop (1989) who 
found that the level of hepatic MUP mRNA in different Balb/c females 
varied from 1 to 14% of the male level. This variation was specific to 
MUP mRNA and was not found in other liver mRNAs. As MUPs are hormonally 
regulated it was suggested that this was due to variation in the 
hormonal status of individual mice. 
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IDENTIFICATION OF SEQUENCES INVOLVED IN MUP AND a2.-GLOBULIN 
Transcriptional regulation 
The developmental timing and sexual dimorphism of MUP expression are 
regulated at the level of transcription. Higher levels of transcription 
are found in adult males (96 times higher) than in seven day old males. 
Higher transcription rates were found in adult males (7 times higher) 
compared with adult females (Derman, 1981). The transcription rate in 
females can be raised to the level seen in males by treatment with 
testosterone (Al-Shawi et al. , 1988). Since testosterone can be replaced 
by a combination of pulsatile GM and thyroxine then the action of these 
hormones also occurs at the level of transcription. It is not known 
whether GM and thyroxine both act directly on hepatocytes and in 
particular whether there is a direct receptor mediated effect of 
thyroxine on MUP transcription. In isolated hepatocytes the tran-
scription of HUP genes was not raised by treatment with GM or thyroxine 
(Speigelberg and Bishop, 1988). This may be because the pattern of GM 
administration is crucial to increase transcription of MUP genes. 
Cell Culture 
Within the liver, MUP genes are expressed only in differentiated 
hepatocytes. Expression of MUP genes is rapidly lost in isolated 
hepatocytes and hepatomas along with that of many other liver specific 
genes (Spie.gelberg and Bishop, 1988; Held et al., 1989). This means 
that it is not possible to study the regulation of MUP gene expression 
in these systems. Expression of ;-globulin is reduced during the 
acute phase and transcription of a 2 -globulin falls rapidly during the 
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first 24 hours after acute phase stimulation (Schreiber et al., 1989). 
This further mode of regulation suggests that the expression of MUP and 
a2 -globulin genes can easily be switched off by stress related 
factors. 
Transgenic mice 
The sequences which direct both liver-specific and sexually dimorphic 
expression of group 1 MUP genes reside in 2.2kb of 5' proximal 
sequences. Three constructs containing this promoter fragment directed 
expression of three different reporter genes in a liver specific manner 
and two also in a sexually dimorphic manner in transgenic mice (Held 
et al., 1989; Al-Shawi et al., 1988; Al-Shawi et al., submitted). The 
sequences which direct liver specific and sexually dimorphic expression 
of a 2 -globulin are contained within a 7kb fragment containing 2.7kb of 
5' proximal DNA and an a2 -globulin structural gene (Costa Scares et 
al., 1987). Similar regions probably direct tissue specific expression 
of all MUP genes since a 7kb fragment of the submaxillary gene Mupl.5b 
including 4.4kb of 5' proximal region contains all of the sequences 
necessary to direct expression to the submaxillary gland (Shi et al., 
1989) 
The 7kb fragment of a2 -globulin also contains sequences necessary for 
expression in the preputial gland and a low level of expression in the 
submaxillary and lachrymal gland. Expression of endogenous a 2 -globulin 
is normally found in these tissues. Similar sequences may occur in MUP 
genes because the 2.7kb proximal promoter fragment directs a low level 
of expression of reporter genes to the preputial gland (Held et al., 
1989; Al-Shawi et al., 1988 and submitted). The preputial gland is not 
a normal site of endogenous MUP expression which suggests that these 
42 
elements are repressed in endogenous MUP genes. 
It is not known which part of the 2.7kb 5' proximal promoter region 
contains the cis-acting sequences necessary for MUP expression. The 5' 
proximal 300bp alone cannot direct liver specific expression of hsvTl< 
in transgenic mice, however studies in vitro using 300bp of a 2 ,-
globulin showed that this region contains all sequences necessary for 
liver specific expression in vitro. 
Nuclear Extracts 
The promoters of two a 2 -globulin genes have been studied in vitro. In 
one case male-specific transcription of the a 2 -globulin gene was 
achieved whereas in the other case it was not (Sarkar and Feigelson 
1989; Sierra, 1990). The nuclear extracts used in both cases were made 
using the same method and the differences between the two experiments 
was the particular a 2 -globulin gene studied and the presence or 
absence of the coding region. Male-specific transcription was achieved 
using the a construct containing part of the a20-globulin gene 207 
containing 639bp of 5' sequence and 1395bp of coding region including 
intron 3 which is known to contain binding sites for nuclear factors 
in expressing tissues (Sarkar and Feigelson, 1989; Choy et al., 1989). 
Male specific transcription was not achieved using 3kb of the 5' 
promoter region from an unidentified a 2,-globulin gene and a G-free 
cassette reporter (Sierra, 1990). This construct and a deletion 
containing 245bp of the 5' proximal region were able to drive liver 
specific expression of a G-free cassette. The 245bp region contained 
binding sites for 6 factors present in both liver and spleen nuclear 
extracts, some of which showed different binding in liver and spleen. 
Oligonucleotides containing binding sites for known trans-acting 
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factors in the albumin promoter were used in competition experiments 
to show that one of the factors was C/EBP and another was pseudo NFl, 
both of which are liver enriched. 
AIMS OF THESIS 
In general liver-specific, hormonal and developmental regulation of 
gene expression occurs when proteins bind in a sequence-specific manner 
to DNA. Small changes in the sequence of the DNA to which these 
proteins bind will affect their binding and thus the way in which a 
gene is regulated. The group 1 MU? genes are very closely related so 
that their sequences are almost identical yet some genes respond to 
hormones in different ways than others. By examining the differences 
in sequence of group 1 genes, changes in sequence which could 
potentially be responsible for causing the different types of hormonal 
regulation can be identified. In order to do this unique group 1 MU? 
genes must be identified and their regulation characterized. In 
practical terms this means that group 1 mRNAs or proteins must be 
uniquely distinguished. 
Two methods were used to identify and distinguish group 1 Mu? genes. 
Firstly, short oligonucleotides were designed which could distinguish 
between sequences which differed by one base pair and hence distinguish 
between closely related group 1 mRNAs. Secondly, group 1 proteins which 
differ by a single amino-acid were separated by IEF and the products 
of particular group 1 genes were identified by translating them in vi-
tro. Oligonucleotides and IEF were then used to compare the regulation 
of group 1 MU? genes. The sexually dimorphic expression of allelic 
group 1 genes was compared in two inbred strains of mice. The induction 
of different subsets of group 1 MU? genes was compared in CM deficient 
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mice treated with different patterns of GM. Subsets of group 1 MUP 
genes were identified which are regulated differently and their 
regulation is discussed. 
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SINGLE COPY GROUP 1 MUP GENES 
All MU? genes map to a single locus on chromosome 4 (Bennettet al., 
1982; Bishop et al., 1982) called map-I. Most inbred strains of labor-
atory mice carry one of two principal alleles at this locus which are 
thought to derive from two alleles present in the wild population of 
Mug. in. domesticus ( Hudson et a.!., 1967; Duncan et a.!., 1988). Balb/c 
mice are amongst those with the map_i1 allele whereas C57BL/6 are 
amongst those with the map-ft allele and these strains are the most 
commonly used in studies of MUP genes and their regulation. Both have 
approximately thirty-five MU? genes which can be divided into four 
groups on the basis of sequence similarities (Al-Shawi et a.!., 1989). 
The four groups, named groups 1, 2, 3 and 4, are of similar size in 
both strains. Groups 1 and 2 contain twelve to fifteen genes (Bishop 
et al., 1982), groups 3 and 4 contain two to four genes (Shahan et a.!., 
19876; Kuhn et a.!., 1984). The aim of this project is to identify single 
copy group 1 MU? genes and compare their expression in the two strains. 
Thirty-two group 1 genomic clones have been isolated from Balb/c and 
C57BL/6 libraries and analysed by restriction site mapping (Held et 
a.!., 1987; Al-Shawi, 1985). Although the maps are very similar, many 
clones or small groups of clones have characteristic restriction 
fragments which distinguish them from the others. By mapping group 1 
genes in genomic DNA, some of these fragments can be shown to be 
present in one copy per haploid genome and the small group of clones 
must represent multiple cloning events of the same unique MU? gene (Al-
Shawi et a.!., 1989). when a characteristic fragment is present in more 
than one copy per genome the small group of clones may be derived from 
different genes, and it is quite likely that these genes have 
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nucleotide differences which were not detected by restriction mapping. 
There is a region of considerable divergence starting fifty base pairs 
upstream of the transcription start site of each group 1 gene. This 
hypervariable region contains a stretch of A residues or A and C 
residues which varies in length between thirteen and sixty-two 
nucleotides. Sequence data for this region has been obtained from 
fourteen group 1 genomic clones isolated from either Balb/c or C57BL/6 
(Al-Shawi et al., 1989, Held et al., 1987). Of the fourteen sequences, 
only two are identical in this region. This suggests that the 
hypervariable region is probably distinct in each group 1 MUP gene. The 
sequence of the hypervariable region is a useful method for comparing 
and distinguishing genomic clones which have identical restriction 
maps. 
Two single-copy group 1 genes have been identified by restriction site 
mapping of genomic DNA in each of the two inbred strains. The four 
genes consist of two pairs of nearly identical genes which are referred 
to here as Mup-1.1, Mup-1.IB!, Mup-1.1Ct and Mup-1.1G!. The two 
members of each pair are thought to be closely related by descent and 
each strain contains one member of each pair. Genomic and cDNA clones 
of these genes have been isolated (Al-Shawi, 1985; Kuhn et al., 1984; 
Held et al., 1987; see Table 1.1). clones of Mup-1. IS' have identical 
restriction naps but differ from clones of Mup-1. 1 by one restriction 
site. The hypervariable region of a Mup- 1. IIP genomic clone, cL5 is 
different from that of a Mup-1. 1B genomic clone, BS1 in the central 
part but identical in the flanking regions. This suggests that the two 
hypervariable regions are recent expansions or deletions of the same 
original sequence (Al-Shawi et al., 1989). 
All genomic clones of Mup-l. IC- and Mup-I. iG have the same restriction 
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TABLE 1.1 Unique group 1 MUP genes 
NAME OF UNIQUE 	NAME OF 	STRAIN GENO- 	eDNA 
GENE 	RESTRICTION STRAIN- 	 MIC 	CLONES 
SITE 	SPECIFIC 	 CLONES 
DIFFERENCE GENE 
Mup-1.1C lack EcoRI Mup-1.1c! Balb/c aLl 	cLiv6 







Mup-1.1B Lack ECORI 
	
Mup-1.1 	Balb/c ES1 	cLivi 
site 3' to 	 ES1 07 
exon 7 
Mup-1. ? 	C57 	CLS 
CL 1 0 
map (Figure 1.1). The sequences of the hypervariable regions from two 
Mup-1.1O clones; aLl and 5,1-31 and one Mup_1.1Có_ clone; BL6-11 have 
been determined. Each hypervariable region differs from the others by 
one nucleotide which is a very small difference compared with the 
additional 43 nucloetides in some group 1 genes (Held et a]., 1987; Al-
Shawi et al., 1989). The sequence similarity between group 1 genes in 
800bp of the 5' proximal region is very high (5 to 10 nucleotide 
differences) (Held et al., 1987). In the 5' proximal regions of BL1, 
53-31 and BL6-11 there are only three nucleotide differences which 
suggests a close relationship. aLl and BJ-31 were derived from two 
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FIGURE 1.1 
Restriction maps of MUP genomic clones in lambda vectors. Diagram 
extracted from Al-Shawi (1987, THESIS) with lambda clones from Held et 
al., (1987) (BL6-3, 8L6-42, BL6-11, BJ-31, BL6-25 and BL6-51) inserted 
in appropriate places. The clones have been mapped with the restriction 
enzymes shown. Clones from Held et al. (1987) were mapped using a cDNA 
clone as a probe which means that if there is more than one restriction 
site for an enzyme outside the mRNA region then the more distant 
restriction sites were not identified. The clones 8S6 down to BL6-51 
inclusive are clones of group 1 MUP genes. The clones BS-2 to BL-15 
inclusive are clones of group 2 MU? genes. The clones BL-8 to CL-12 
inclusive are clones of group 3 or 4 MUP genes. The clones BS-6, BL-14, 
BL-7, BS-5, BJ-31, BL-1, BS-1, BS-107, BS-2, BS-3, BS-4, BL-25, BL-15 1  
BL-8 and BL-2 are clones isolated from Balb/c libraries. The other 
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different Balbfc substrairis which may account for two single nucleotide 
differences (one of which is in the hypervariable region) in the first 
350bp of 5' proximal region of the two clones. There is I single 
nucleotide difference within the coding regions of Mup-1.IG and Mup-
1. IC* which can be used to distinguish between mRNA from these two 
genes. 
Group 1 mRNAs can differ by only a single nucleotide change which means 
that very stringent techniques have to be used to distinguish mRNA from 
a particular MUP gene from all the other group 1 mRNA in the liver. 
Four techniques have been used to distinguish between very similar 
mRNAs; ribonuclease protection, hybridization of oligonucleotides, 
primer extension and the polymerase chain reaction (PCR). The use of 
these four techniques is described in Table 1.2. 
Table 1.2 Methods of Distinguishing Closely Related RNAs 
RIBONUCLEASE PROTECTION 
The anti-sense RNA from a single cloned template is hybridized to the 
mixture of mRNA molecules. The RNA which is perfectly complimentary to 
the probe will protect it throughout its length. The probe hybridized 
to mismatched RNAs will be cleaved internally. 
HYBRIDIZATION OF OLIGONUCLEOTIDES 
Short oligonucleotides will form stable hybrids with perfectly matched 
targets, however, if there is a mismatch of a single nucleotide or more 
the hybrids will be unstable under stringent hybridization conditions. 
PRIMER EXTENSION 
The primer binds to a site adjacent to the sequence difference. The 0In 51 
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extension is then carried out using a dideoxynucleotide or omitting a 
nucleotide in such a way that the reaction will terminate at a 
different point when the primer is bound to the desired target than if 
it is bound to the closely related sequences. The different length 
extension products can be distinguished by electrophoresis. 
THE POLYMERASE CHAIN REACTION (PCR) 
A small region of the closely related RNAs is amplified between two 
primers. The amplified fragment from the RNA of interest is distin-
guished from the others by restriction site polymorphisms. If the 
region amplified is short it is possible to use enzymes which cut 
frequently and many differences can be distinguished in this way. 
Mup-1.1B, Mup-1.ICS' and Mup_1.lc! mRNAs were distinguished by hybrid-
ization to three specific oligonucleotides. Two of the oligonucleotides 
were designed and used by McIntosh and Bishop (1989) to study the 
expression of Mup-1. Ic! and Mup-I. 1W in male and female Balb/c liver. 
The probes were designed by comparing six group 1 coding sequences 
which were known. These consisted of five group 1 coding sequences from 
Balb/c including three cOMA clones (Kuhn et al., 1984; Shahan et al., 
1987,j Chave-Cox, 1986) and three genomic clones (Clark et al., 1985) 
and one group 1 cOMA from C572L/6 (Kuhn et al., 1984). As there are 
approximately twelve highly homologous group 1 genes in each strain it 
is possible that there are unknown mRNAs which are identical to the 
probes. In order to test this the oligonucleotide probes were 
hybridized to genomic DNA and group 1 genomic clones derived from both 
Balb/c and C57BL/6. 
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RESULTS 
The sequences of the three oligonucleotides are shown in Table 1.3. 
oBSI and oBLl are the two oligonucleotides designed by McIntosh and 
Bishop (1989). oBL1 does not hybridize to Mup-1.S but this gene can 
be detected by a new oligonucleotide called oBLIRI. oBL1RI crosses the 
sequence in exon 2 of Mup-1. 1 which is an EcoRI site in all MJP genes 
apart from iiup-I.1O and Mup-1.1c!. oBL1RI is therefore specific for 
these two genes. 
Table 1.3 Location of Oligonucleotides 
OLIGO- 	LEN- 	EX- 	 SEQUENCE 	 GENE 
NUCLEOTIDE GTH 	ON 
oBL1RI 	19 	2 	5'GAACTAAGGAITTCTCCAA 	Mup- 
i.ic 
1. ick 
oBLI 	18 	5 	5 'CACATAGTTGTGCAAACC 	Mup- 
i.ic! 
osSi 	18 	3 	5'GATAATTCCGAGCACTCT 	Map- 
1.1B 
* mismatch to other group 1 genes underlined 
oBL1 and oBS1 were hybridized to a number of MUP genomic clones derived 
from Balb/c and C57BL/6 DNA (Table 1.4). oBL1RI was hybridized to the 
three clones which cannot be digested with EcoRI in exon 2 (Al-Shawi, 
1985; Held et al., 1987; Table 1.4). Maps of the four clones which 
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hybridized with oBSI are shown in Figure 1.2. These clones are 
described later. 
Table 1.4 Hybridization of oligonucleotides to NUP genomic 
clones 
OLIGO 	POSITIVE GE- 	NEGATIVE GENOM- CLONES NOT 
NLJCLE- 	NOMIC CLONES 	IC CLONES 
OTIDE 	 TESTED 
CM 3 
oBS1 	ES1 	CL5 	856 	CL3 CL6 BL14 	CM 
855 	CL'lO 	BL7 	CL13 	8331 	BL6-3 
ELi 	CL8 CL9 85107 	BL6-42 
CL11 	 BL6-11 
- 	 8L6-25 
NO - Not Determined 
To estimate how many different genes in Balb/c or C57BL/6 could 
hybridize to oBL1, oBL1RI and oBSl the ol igonucleot ides were hybridized 
to Southern blots of genomic DNA -. The pattern of hybridization obtained 
was compared to the pattern obtained using a group 1 fragment probe 
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FIGURE 1.2 
Restriction maps with five common six base pair cutters (shown) of 
genomic clones which hybridized to the oligonucleotide osSi (shown in 
table 1.2). Restriction site differences between BS-5, CL-5 or CL-10  
and as-i are marked with an asterisk. There are six differences in as-
5, but only one between CL-S, CL-10 and ES1. 
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(G1F) which can hybridize to all group 1 genes. The G1F is a 700 base 
pair PstI restriction fragment from the genomic clone CL5 which 
includes the whole of exon 3. This probe was selected because it is 
expected to hybridize to the same restriction fragment of EcoRI, 
Hindlil or PstI digested group 1 genes as the oligonucleotides. 
In all of the genomic blots shown, restricted MUP genomic lambda clones 
were used as both size and copy number markers. The clones used in 
marker tracks were selected so that, where possible, fragments in the 
marker tracks would be the same size as those in genomic DNA. Figures 
1.3a to 1.3d and 1.7 show the approximate sizes of restriction 
fragments used as markers in Figures 1.4, 1.5, 1.6 and 1.8. The copy 
number was determined by comparing the signal from the band in the copy 
number markers to the signal from the band in genomic DNA. The one copy 
marker contained 150pg of a 45kb lambda clone which was calculated to 
give the same signal as one copy per haploid genome in lOp.g of genomic 
DNA. 
The three genomic clones hybridized with oBL1RI were clones of Mup-
1.1G! or Mup-1.iO (Table 1. 4, Table 1.1; Al-Shawi et al., 1989; Held 
et al., 1987) and the àñ& which also hybridized with oBL1 wo.clone,) 
of Mup-1.Ic (Table 1.4; Table 1.1). The copy number of these genes was 
estimated by hybridizing oBL1 and oBL1RI to genomic DNA. Genomic DNA 
from Balb/c and C57BL/6 was restricted with Mmdlii or Mmdlii and 
EcoRI and hybridized to the G1F probe or the oligonucleotide oBL1 
(Figure 1.4). An identical blot was hybridized to the oligonucleotide 
oBL1RI (data not shown.) It was previously shown that a 5.5 kb Hindili 
fragment is conserved in most group 1 genes of both strains (Al-Shawi, 
1985). In addition, the EcoRI site in exon 2 mentioned previously 
allows the Hindili fragment from all group 1 genes except Mup-1. 1Cb and 
Mup-1. IC- to be cut by EcoRI into two fragments of 3 kb and 2.5 kb. In 
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FIGURE 1.3 
Sizes of restriction fragments detected by the G1F probe in genomic 
clones used as markers in Figures 1.4, 1.5 and 1.6. The genomic clone 
digested to produce each fragment and the region which hybridizes to 
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A Southern blot showing the number of genes per genome of Balb/c and 
C57BL/6 mice which hybridized to the oligonucleotide oBL1. 
The Southern blot contained lojsg of Balb/c or C57BL/6 genomic DNA per 
track cut with Hindill (H) or Hindlil plus EcoRI (RH). The DNA 
fragments used as markers are shown in Figure 1.3a. On the left hand 
side marker tracks contained the equivalent of 50, 5, 2, 1 and 0.5 
copies and on the right hand side, the equivalent of 0.5, 5 and 50 
copies. Each marker track also continued lOp.g of salmon sperm carrier 
DNA. The gel was 0.7% agarose. 
The filter was hybridized twice, firstly to the oligonucleotide 0BL1 
(bottom panel) and then to the G1F probe (top panel). The autoradiogra-
phs were exposed for 1 hour at room temperature (top panel) or 3 weeks 
at -70°C with screens (bottom panel). 
M. 
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a double digest with EcoRI plus Hindlil, the 5.5 Ith Hindlil fragment 
from Mup-?. 7G and Mup-1. IC! is left uncut which allows these genes to 
be distinguished from the others. The 2.5 Id, and the 5.5 kb fragments 
hybridize to the G1F probe. DNA from each strain contains a unique Mup-
I.IC gene (Figure 1.4). The 5.5 kb HindlIl fragment of this gene which 
is not cut with EcoRI is present at the same level as the 1 copy 
marker. The lower panel shows that only the 5.5 kb band derived from 
Mup-1.1C hybridizes to the oligonucleotide oBL1 and that oBL1 
hybridizes to DNA from Balb/c not DNA from C578L/6, thus oBLI hybrid-
izes with Mup-1.1C but not Mup-1.1&. The oligonucleotide oBL1RI 
hybridized to the 5.5 Ith band derived from Mup-I. IC in both strains but 
also hybridized to other bands of non-MUP origin (data not shown). Thus 
oBL1RI hybridizes with Mup-I.1C! and Mup-I.1G. This confirms that 
theie is one copy of Mup-I.1C in the genome of each strain and also 
shows that Mup-I. Ia is different to Mup-I. Hi. 
oBS1 hybridized with clones of Mup- I.I (BSI) and Mup- I.I (CL5 and 
CL10), however, it also hybridized with another clone derived from 
Balb/c which was not a clone of Mup-I. IB (Figure 1.2; Table 1.4; Table 
1.1). Thus oBS1 is not specific to Mup-I.IB!. In order to determine the 
number of genes in each strain which could hybridize to oBS1 restricted 
genomic DNA was hybridized with oBS1 and the G1F probe. By hybridiza-
tion to the G1F probe DNA from Mup-1. lB can be distinguished from DNA 
from all other group 1 genes when cut with EcoRI (Table 1.1). Similar-
ly, Mup- LI can be distinguished from Mup-1.I when cut with PstI 
(Figure 1.2). 
When MUP genomic clones are digested with EcoRI, four different 
fragments are produced which can hybridize to the G1F probe (Figure 
1.3b). In EcoRI digested DNA from both strains, the G1F probe 
hybridized to four fragments (Figure 1.5). The 4.2kb, 6.3kb and 7.9kb 
FIGURE 1.5 
A Southern blot of EcoRI digested genomic DNA hybridized with the 
oligonucleotide oBS1. Tracks contained 10 ig of EcoRI digested Balb/c 
or C57BL/6 genomic DNA, or markers. The fragments present in marker 
tracks are shown in Figure 1.3b and c. On the left hand side marker 
tracks contained the equivalent of 50, 5, 2, 1 and 0.5 copies and on 
the right hand side the equivalent of 0.5, 5 and 50 copies. The gel was 
0.6% agarose. 
The filter was hybridized twice, firstly to the oligonucleotide oBS1 
(bottom panel) and then to the G1F probe (top panel). The filters were 
exposed for 1 hour at room temperature (top panel) or 3 weeks at -70 0c 
with screens (bottom panel). 
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fragments are the same size as restriction fragments from MUP genomic 
clones. The fragment which is )12kb is probably derived from Mup-1.1C 
(Duncan et al., 1988; Shahan et al., 1987b). The G1F probe hybridized 
more strongly to the 4.2kb fragment than the other EcoRI fragments, 
which means that this fragment is derived from more genes than the 
others. 
The oligonucleotide oBSi hybridized to the 4.2kb and 6.3kb fragments 
in genomic DNA from both strains (Figure 1.5) but not to the 7.9kb or 
>12kb fragments. The 4.2kb and 6.3kb fragments are the same size as 
those derived from the clones BS5 (4.2kb) and BS1 (6.3kb) which 
hybridize to oBSI (Figure 1.5). Previous work by Al-Shawi et al., (1989) 
suggested that Map-I. lB is the only gene which contributes a 6.3kb 
fragment (Table 1.1). The above result shows that Mup-1.1B hybridized 
oBSl in both strains. The 4.2kb fragment is contributed by the 
remaining group 1 genes except Map-i. IC whereas the 7.9kb fragment is 
probably contributed by group 2 genes (Figure 1 .1). Several group 1 
clones do not hybridize to oBSl (Tables 1.1 and 1.4). A comparison of 
the intensity of the hybridization signal using the oBS1 probe to that 
using the G1F probe reveals that over half of the group 1 genes which 
contribute to the 4.2kb band hybridize to oBS1. Hence, rather than oBSl 
being specific to Map-I. 15, it can in fact hybridize with over half of 
the group 1 genes in both strains of mice. 
Two further mapping experiments were carried out to determine whether 
there were any differences between the Balb/c and C57BLI 6 genes which 
were able to hybridize with oBS1. The genes were mapped with PstI and 
MspI. The two Map-i. i clones (CL5 and CL1O) differ from the Map-I. I 
clone (BSI) in these digests (Figure 1.2). 
When MIJP genomic clones are digested with PstI, three fragments of 0. 7, 
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1.1 and 3.7kb are produced which can hybridize with the G1F probe 
(Figure 1.3d). Five genomic clones isolated from C57BL/6 DNA produce 
the 0.7kb band which is not produced from any of the clones from 
Balb/c. Thus the 0.7kb fragment may be detected with the G1F probe in 
PstI digested genomic DNA from C57BL16 but not Balb/c. Differences in 
the levels of hybridization to the 0.7kb fragment was indeed observed 
(Figure 1.6). Using the G1  probe, the 0.7kb PstI fragment was detected 
in Balb/c DNA at a very low level of less than one copy per genome. The 
0.7kb PstI fragment was detected at a level equivalent to about 2 
copies in C57BL16 DNA. This difference between Balb/c and C57BL/6 DNA 
is also detected using the oligonucleotide oBS1. This suggests that two 
to three group 1 genes in the C57BL/6 genome contribute the 0.7kb Pst 
I fragment and at least one of them can hybridize with onSi. No group 
1 genes in Balb/c contribute a 0.7kb PstI fragment, but the weak 
hybridization of the G1F probe to this fragment means that it may be 
derived from a group 2, 3 or 4 gene in this strain. The other group 1 
genes contribute to the 1.1kb PstI fragment and approximately half of 
them hybridize to oBS1. This indicates that there is a difference 
between the group 1 genes in Balb/c and C57BL/6 and the oligonucleotide 
oBSi hybridizes to different genes in the two strains. 
In previous mapping studies on group 1 MUP genomic cloneS, Al-Shawi 
(1985) found that several group 1 genomic clones had different MspI 
fragments. These are shown in Figure 1.7. An attempt was made to 
distinguish group 1 genes which hybridized with the oligonucleotide 
oBSI from those which did not by digesting genomic DNA with MspI. The 
MspI fragments present in genomic clones used as markers in Figure 1.8 
are shown in the upper part of Figure 1.7. They represent ten different 
MspI fragments derived from six different group 1 MUP clones. TheG1F 
probe overlapped the MspI site in intron 2 and hybridized with two MspI 
fragments in some genes and clones. In Figure 1.8 the C57BL/6 genomic 
FIGURE 1.6 
A Southern blot of Pst I digested genomic DNA hybridized with the 
oligonucleotide osSi. Tracks contained lOpg of Pst I restricted Balb/c 
or C57BL/6 genomic DNA or marker DNA. The fragments present in marker 
tracks are shown in Figure 1.3d. On the left hand side marker tracks 
contained the equivalent of 50, 5, 2, 1 and 0.5 copies and on the right 
hand side the equivalent of 0.5, 1, 2, 5 and 50 copies. The gel was 2% 
agarose. 
The filter was hybridized twice, firstly to the oligonucleotide oBsi 
(bottom panel) and then to the G1  probe (top panel). The filters were 
exposed for 1 hour at room temperature (top panel) or 3 weeks at -70 0c 
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Sizes of MspI restriction fragments detected by the group I fragment 
probe in genomic clones used as markers in the genomic blot shown in 
Figure 1.8. The genomic clone digested to produce each fragment and the 
region which hybridizes to the GIF probe (in some cases part of two 
fragments) are indicated. 






A Southern blot of lisp I digested genomic DNA hybridized with the 
oligonucleotide oBS1. Tracks contained 1049 of lisp I digested Balb/c 
or C57BL/6 genomic DNA or marker DNA. The fragments present in marker 
tracks are shown in the upper part of Figure 1.7. On the left hand side 
marker tracks contained the equivalent of 50, 5, 2, 1 and 0.5 copies 
and on the right hand side the equivalent of 0.5, 1, 2, 5 and 50 
copies. The gel was 0.6% agarose. 
The filter was hybridized twice, firstly to the oligonucleotide oBS1 
(bottom panel) and then to the group I fragment probe (top panel). The 
filters were exposed for 1 hour at room temperature (top panel) or 3 


















- 2.5 2.9 
1.5 
do 
MARKERS 	BaIb 057 MARKERS 








SINGLE COPY GROUP 1 141W GENES 
DNA appeared to be under-loaded. Bands of 2.9, 4.1, 5.6, 7.2, 10 and 
12.3kb are detected with the G1F probe in genomic DNA from both 
strains. A 1 .5kb band is present in both Balb/c and C57BL/6 genomic DNA 
but is only detected in the C57BL/6 track when the autoradiograph is 
exposed for longer than that shown. Additional faint bands are seen in 
DNA from both strains. 
In the marker tracks, only two fragments hybridize to the oligonucleo-
tide oBS1, a 5.3kb fragment from CLS and a 4.1kb fragment from B55 
(Figure 1.8). In genomic DNA from both Balb/c and C57BL/6, five 
fragments (4.1, 5.4, 7.2, 10 and 12.3kb) hybridize to the oligonucle-
otide which derive from at least five different group 1 genes. The 
fragments are the same size in both strains although the amount of each 
fragment detected is different. The 4.1 and 5.4kb fragments were 
detected at the same level in both strains. The 7.2, 10 and 12kb 
fragments were detected at a higher level in Balb/c DNA. Therefore 
there is a difference between the number of genes contributing each 
fragment in the two strains. This is consistent with previous work 
using a different group 1 probe (Al-Shawi, 1985). 
DISCUSSION 
Three oligonucleotides oBL1, oBL1RI and oBS1 were designed to 
distinguish Mup-1.B, Mup-1.10 and Nup-1.I0- mRNA in order to study 
the expression of four single copy group 1 genes in Balb/c and C57BL/6 
mice. The group 1 MUP genes are highly homologous and, as mentioned, 
the sequence of only five Balb/c and one C57BL/6 group 1 coding regions 
are known. Hence the oligonucleotides were hybridized to genomic DNA 
in order to determine whether they would hybridize to any unknown group 
1 genes and therefore to more than one MUP mENA. 
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cELl and oEL1RI, which were designed to:detect Map-I. IC mRNA, did not 
hybridize to any unknown group 1 genes. oBL1 could only hybridize to 
Mup-I.IcY and not Mup-I.Ict oBL1RI could hybridize to Mup_I.lc! and 
Map-I. IG but also cross-hybridized to non-MUP sequences in genomic 
DNA. The origin of this hybridization is not known. oBLi hybridizes to 
just one group 1 gene, Mup- I.IC! and it can potentially be used to 
distinguish Map-i. IC inRNA from all other group 1 mRNA in Balb/c liver. 
The oligonucleotide oBL1RI hybridized to two group 1 genes, Map-1.1c 
and Map-I. 1 C, one from each of two inbred strains of mice. oBL1RI can 
be used to compare the expression of Map-i. i and Map-I. I in Balb/c 
and C57BL/6. 
oBL1 can distinguish mRNA from Mup-I.UY and Mup-I.I& This is 
potentially useful to enable the expression of the two genes to be 
studied in recombinant inbred (RI) strains or in F 1 hybrids between 
Balb/c and C57BL/6. Previous experiments using recombinant inbred (RI) 
strains or F 1 hybrids showed that secretion of MUP proteins in urine 
or the level of MUP mRNA is modified by a number of trans-acting loci 
(Szoka and Paigen, 1978; Berger and Szoka, 1981; Ma, 1987). The 
ol igonuc leot ides oBLI and oBL1RI could be used to determine whether 
these trans-acting loci affect the level of specific group 1 mENAs. 
The MtJP gene family arose by duplication after which mutations occurred 
which then spread throughout the family by unequal crossing over or 
gene conversion (Al-Shawi et al., 1989). Mup- I.IC! and Mup- i.IG are 
almost identical but both are different from many other MUP genes in 
the same strains (Al-Shawi et al., 1989; Held et al., 1987). The close 
relationship of Map_I.IG! and Mup-I.IC suggests that both are 
descended from the same gene. The single mutation in the coding region 
which distinguishes Map-I. IC! is not found in any other MUP gene. 
Unless it is conserved by selection, one would hypothesize that this 
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mutation would eventually either spread to the other group 1 genes or 
be lost. 
oBSi, which was designed to detect Mup- LIB, hybridized not only to 
Mup-1.IB but also to several other group 1 genes in both strains of 
mice. oBS1 hybridized to four group 1 genomic clones of which BS1, CL5 
and CL10, are clones of Mup-1. lB whereas BS5 is not. Mapping experi-
ments were carried out on the genes which hybridized to oBS1. Genomic 
DNA from the two strains was digested with three enzymes; EcoRI, PstI 
and MspI. In two of these digests there was a deference between the 
fragments detected in Balb/c and C57BL1 6 DNA. The results showed that 
a 0.7kb fragment was detected in Pst I digested C57BL/6 DNA but not 
Balb/c DNA. Using a different probe, Al-Shawi (1985) detected a 0.7kb 
Pst I fragment in both strains. This difference could be due to the 
ability of the previous probe (which was longer than 0.7kb) to 
hybridize with another fragment in Balb/c genomic DNA. The Pst I site 
in intron 2 responsible for generating the 0.7kb fragment may have been 
involved in a gene conversion event (Al-Shawi, 1985). Mup-1.1 and 
MupI. l are closely related but the Pst I site in intron 2 is only 
present in Mup- l.l. The site could have been introduced into several 
C57BL/6 genes including Mup-l. 1LP or removed from several Balb/c genes 
including Mup l.l by a gene conversion event. 
The strain difference observed in genomic DNA digested with Msp I was 
quantitative rather than qualitative. Quantitative differences in the 
hybridization to fragments in Msp I digested DNA from both strains was 
previously observed using another probe (Al-Shawi, 1985). The location 
of Msp I sites may differ in closely related genes more than the other 
restriction sites because the recognition sequence for MspI contains 
a CpG methylation sequence. This may lead to frequent mutation of "C 
to T and thus loss of Msp I sites. Five different fragments in Msp I 
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digested DNA hybridized with the oBS1 probe which indicates that at 
least five different genes are detected with this oligonucleotide. 
McIntosh and Bishop (1989) hybridized oBS1 to Balb/c liver RNA in order 
to determine whether the expression of Mup-1. l was different in males 
and females. mRNA which hybridized with oBS1 was present in male liver 
RNA at one third the level of Mup-1.1G' RNA (which was detected with 
the oligonucleotide 0BL1). In female Balb/c liver the level of 
hybridization with oBS1 was extremely low, whereas the level of Map-
I. IC mRNA in females was only about eleven fold lower than that in 
males. They concluded that mRNA detected with oBS1 was much more 
sexually dimorphic (250 times) than Mup-1.1O RNA (11 times). Therefore 
oBSl hybridizes to a very sexually dimorphic MUP mRNA in Balb/c mice. 
The results shown here indicate that up to five different group 1 genes 
may contribute to this sexually dimorphic mRNA. 
Al-Shawl et al., (1989) suggested that closely related MUP genes formed 
sub-families which had the same pattern of expression. Genes which 
hybridize to oBS1 may be members of one such sub-family. Alternatively 
some of the five genes may be comparatively silent. Shi et al.,(1989) 
suggest that many of the twelve to fifteen group 1 genes are silent. 
In the Balb/cJ substrain half of the group 1 MUP genes are deleted and 
none of the remaining six to eight are expressed (Duncan et al., 1988; 
Shi et al., 1989). There are two possible causes of this loss of group 
1 expression. The functional group 1 genes could have been deleted 
leaving only non functional ones, alternatively the loss of expression 
may be due to the loss of an enhancer which affects the expression of 
all MU? genes. Map-I. Ic! is known to be capable of expression however 
the EcoRI fragment which is thought to be derived from Map-I. 1  is not 
detected with a group 1 MU? probe in these mice which makes it very 
likely that this gene has been deleted. 
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As mentioned in the introduction, there are several methods available 
to distinguish between closely related sequences and it may be possible 
to use a different method to find out if other MLJP mRNAs are present 
in the liver. Ribonuclease protection has the advantage over hybridiza-
tion to oligonucleotides in that the probe covers a large section of 
mRNA. It is therefore possible to identify mismatches between mRNAs and 
the probe over the whole mRNA sequence. Other group 1 genes expressed 
in the liver might be identified in this way. 
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If the protein product of each group 1 MUP gene can be identified then the 
different proteins synthesized in males and females or in mice treated 
with GH and thyroxine would be indicative of the genes being expressed. 
In this way genes which respond differently could be identified. There is 
no reason to suppose that genes with the same protein product are 
regulated in the same way, however, if a protein is not present in urine, 
it is likely that none of the genes which code for that protein are 
expressed. If a protein is present in urine it is not possible to 
determine the level at which each gene which codes for that protein is 
expressed and the products of each gene must be distinguished in some 
other way. 
Many group I MUP genes have different coding sequences and, as mentioned 
in chapter 1, six different group 1 coding sequences are known, of which, 
five are from Balb/c and one is from C57BL/6. There are one or two 
nucleotide differences between the six coding sequences and in some cases 
this causes a difference of a single amino-acid in the protein. MUPs which 
differ by a single amino-acid can be separated by narrow range TEF 
providing that the amino-acid change affects the isoelectric point. By a 
combination of IEF and SDS PAGE, seven different MUPs have been identified 
in C57BL/6 urine (Kuhn et al., 1984). MUPs present in urine are 
synthesized in the liver (Finlayson et al., 1965) and hybrid selection was 
used to separate group 1 and group 3 liver mRNA and thus identify which 
proteins in urine are products of the two groups of genes (Kuhn et al., 
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1984). The five proteins synthesized in vitro from group 1 mRNA were 
identical to five proteins in urine named Mm's 1 to 5. The four or more 
proteins synthesized in vitro from group 3 mRNA (which codes for a protein 
with an N-linked glycosylation site) were glycosylated and could easily 
be distinguished from the group 1 proteins (Ma, 1987; Kuhn et al., 1984). 
These were referred to as MUP 6. 
TABLE 2.1 Proteins coded by MUP genes 
GENOMIC CLONE 	MOUSE STRAIN 	PROTEIN 
2L6-25 	 C57BL/6 	 MUP2 
BL6-51 	 C57BL/6 	 MUP2 
BL6-11 	 C57BL/6 	 MUP3 






BJ-31 	 BALB/C 	 MUP2a 
Different sets of MUPs are synthesized in Balb/c and C57BL/6 (Clissold and 
Bishop, 1982). The glycosylated MUPs appear to be identical in the two 
strains (Sampsell and Held, 1985; Kuhn et al., 1984; Ma, 1987) and the 
differences are due to group 1 genes. In Balb/c there are three group 1 
MUPs and these have similar isoelectric points to the C57BL/6 MUPs 2, 4 
and 5 (Sampsell and Held, 1985; Clissold and Bishop, 1982). 
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Held et al. (1987) identified the products of MUP genomic clones from 
C57BL/6 and Ealb/c by transfecting MUP clones into mouse L-cells in tissue 
culture and isolating the secreted protein from the cell medium. The 
products which they identified are shown in Table 2.1. In the work 
described here, the protein products of three Balb/c group 1 genes and one 
group 3 gene were identified. Proteins made by males and females were 
compared so that inferences could be drawn about the expression of these 
four genes. 
RESULTS 
The proteins made in vitro from total mouse liver mRNA and proteins 
isolated from urine of a mouse of the same sex and strain were compared 
by loading them in adjacent tracks on one dimensional IEF gels (Figure 
2.1). In agreement with previous work (Knopf et al., 1983), MUPs 1 to 5 
synthesized in vitro comigrated with MUPs 1 to 5 from urine, whereas MUP 
6 from urine which has been shown to be glycosylated (Ma, 1987; Kuhn et 
al., 1984) was not found amongst MUPs synthesized in vitro. The 
alternatively glycosylated MUPs synthesized in vitro can be identified on 
the basis of their molecular weight (Figures 2.5 and 2.7). These MUPs are 
discussed later. Several proteins (0, Figure 2.1) were synthesized in 
vitro which did not comigrate with MUPs from urine. These may be other 
liver proteins as they were not observed when hybrid selected MUP mRNA 
rather than total liver rnRNA was translated (Knopf et al., 1983). 
cDNA clones of three group 1 genes and one group 3 gene from Balb/c were 
used to make MUP proteins. The origins of the four cDNA clones and the 
genomic clones with the same coding sequence are shown in Table 2.2. The 
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FIGURE 2.1 
Isoelectric focusing gel showing the comigration of urinary proteins 
(left) with proteins synthesized in vitro from liver RNA (right). 
Tracks contained lOjig of urinary protein or 210,000cpm (female), 
41,000cpm (male) synthesized proteins labeled with 35S methionine. The 
gel was stained with coomassie blue, dried, then autoradiographed for 
44 days at -70 0c with screens. 
In vitro translation products made from liver RNA from Balb/c and 
C57BL/5 males and females contain different amounts of 
MUP4. In the male products the level of MUP 4 is lower in Balb/c than 
C57BL/6 whereas in the female products it is lower in C578L/6. 
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URINARY PROTEINS IN VITRO TRANSLATION 
PRODUCTS 
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cDNA clones were subcloned into vectors containing the T7 RNA polymerase 
promoter. Maps of the constructs and the size of the run-off transcripts 
from the Ti promoter after linearization using BamHI are shown in Figure 
2.2. 
TABLE 2.2 Origins of MUP cDNA clones 
NAME OF cDNA 	GROUP ORIGIN OF cDNA 	GENOMIC CLONE 
CLONE 	 CLONE 	 WITH SAME 
CODING SEQUENCE 
cLivl 	 1 	Shahan et al., 	 BS1 
l9Bia 
cLiv6 	 1 	Shahan et al., 	 ELi 
198 7& 
MUP 11 (c856) 	1 	Chave-Cox, 1986 	BS6 
MUP15 	 3 	Chave-Cox, 1986 	 - 
IEF was used to identify the proteins from in vitro translated liver mRNA 
which comigrated with the proteins from in vitro translated run-off 
I 
transcripts (Figures 2.3 and 2.4). The correspondence between group 1 
genes and proteins are shown in Table 2.3. The synthesis of these proteins 
is regulated in different ways. MUPs 2a and 4 are produced in both male 
and female Balb/c liver whereas MUP2b is produced only in males. This 
suggests that the genes ELi and BS6 might be expressed differently to 851 
in Balb/c mice. 
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FIGURE 2.2 
MUP cDNA clones in vectors containing the Ti RNA polymerase promoter. 
The size of run-off transcripts are indicated. ctivi and cLiv6 were 
cloned into pTZ18R (Mead and Szczesna-skorupa, 1986) as EcoRI 
fragments. An EcoRI/BamijI fragment from MUP11 (Chave-Cox, 1986) was 
substituted for an Ecoal/Bamfil fragment from cLivi to create cBS6 which 
has the same coding sequence as the genomic clone BS6. MU? 15 was 
cloned into pT7-1 (Tabor and Richardson, 1985) as an EcoRt/BamBI 
fragment by Ma (1987). 
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FIGURE 2.3 
An isoelectric focusing gel showing the comigration of individual MLJP 
proteins made in vitro with proteins present in urine. Male C57BL/6 (1) 
and BaTh/c (3) urinary proteins are compared with proteins synthesized 
in vitro from male C578L/5 liver RNA (2 and 9), male Balb/c liver RNA 
(4 and 7), cLivi RNA (5), cLiv6 RNA (6) or mup15 RNA (8). 42,000cpm 
were loaded in tracks 2, 4, 7 and 9, 10,000cpm in tracks 5 and 6, and 
20,000cpm in track 8. The gel was stained with coomassie blue, dried, 
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An isoelectric focusing gel showing the comigration of individual MUP 
proteins made in vitro with proteins present in urine. Male and female 
C57EL/6 and Balb/c urinary proteins (left) are compared with proteins 
synthesized in vitro from male C578L/6 liver RNA, male Balb/c liver RNA 
and cBS6 RNA in presence (+) or absence (-) of membranes, 40,000cpm of 
liver translation products and 10,000cpm of B56 protein were loaded. 
The gel was stained with coomassie blue, dried, then autoradiographed 
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TABLE 2.3 Correspondence between cDNA clones and proteins 
cDNA CLONE 	GENOMIC CLONE WITH SAME 	PROTEIN 
CODING SEQUENCE 
cLivi 	 351 	 MUP2b 
cLiv6 	 BrA 	 MUP2a 
cBS6 	 356 	 MUP4 
On IEF gels, the protein from in vitro translated run-off transcripts from 
the group 3 clone MUP15 did not comigrate with any in vitro translated 
proteins from liver RNA (Figure 2.3 track 8). This suggests that the 
protein is synthesized from a minor liver mRNA and is not detected on this 
gel. In vivo the group 3 mRNAs are thought to code for MUP 6 which is not 
synthesized in vitro from liver mRNA, probably because of glycosylation 
differences in vitro and in vivo. There are two types of post-
translational modifications which affect MUP proteins, cleavage of the 
signal peptide (Szoka et al., 1980) and glycosylation. The signal peptides 
vary from 22 amino-acids in the MUP15 protein to 18 amino-acids in most 
group 1 MUPs. Only group 3 MUPs have a glycosylation signal. 
The proteins synthesized in reticulocyte lysates are unprocessed primary 
translation products. When canine pancreatic microsomal membranes are 
added during translation the signal peptides are cleaved off and some 
glycosylation steps are performed. The addition of membranes during the 
translation of mRNA from group 1 genes leads to the processing of the MUP 
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precursor (3, Figures 2.5 and 2.6) to give a lower molecular weight 
protein which is the same size as the majority of MOPs found in urine. 
This is consistent with the removal of the signal peptide. On the other 
hand the addition of membranes during the translation of mRNA from MOP 15 
leads to the production of a higher molecular weight protein (2) (Figure 
2.5). This is consistent with glycosylation (Rothman and Lodish, 1977; 
Goldman and Blobel, 1981). Proteins (6) and (7) in Figure 2.5 are thought 
to be cleaved derivatives of (2). 
In order to determine whether the higher molecular weight protein is 
present in in vitro translated liver mRNA, the proteins were subjected to 
two dimensional gel electrophoresis (Figure 2.7). The first dimensional 
narrow range isoelectric focusing from pH 4 to 6.5 excludes almost all 
other liver proteins. The second dimension was SDS PAGE where the 
glycosylated MOPs are separated from non-glycosylated MOPs by molecular 
weight (Figure 2.7a (6)). when MOPs made in vitro from MOP 15 RNA were run 
on two dimensional gels, four proteins were detected (Figure 2.7f). There 
was a single higher molecular weight protein which suggests that MOP 15 
mRNA can be translated to give a single glycosylated product. There were 
three lower molecular weight proteins which may be partially processed. 
In in vitro translated liver mRNA from either BalbJc or C57BL/6 (Figure 
2.7b and d), two higher molecular weight proteins were detected. The fact 
that MOP 15 mRNA gave only one product suggests that these two proteins 
are translated from two different group 3 mRNAs. Both male and female in 
vitro translated liver mRNA (data not shown) contained two higher 
molecular weight proteins indicating that the same group 3 proteins are 
made in the livers of male and female mice. 




15% SOS PAGE showing the molecular weight of MUPs translated in vitro 
from male C57BL/6 or Balb/c liver mRNAs or individual MUPs (cLivi, 
cLiv6 and MuplS) in the presence (+) or absence (-) of membranes. The 
processed MUPs (4) were identified by their comigration with proteins 
from male Balb/c urine and by molecular weight markers run in tracks 
on either side of the gel (not shown). 
Protein (1) is the product of endogenous RNA present in the reticulo-
cyte lysate. Protein (5) comigrates with haemoglobin. Proteins 2 to 4, 
6 and 7 are products of MUP mRNA. 
The number of counts loaded were 42,000 cpm (Male C57BL/6 (-) and (+) 
and Balb/c (-)), 21,000 cpm (Balb/c (+))and 10,000 cpm (individual 
MUP5). The gel was. soaked in amplify (Amersham) after coomassie blue 
staining and autoradiographed for 7 days at -70°C with screens. A 
shorter exposure showed bends 3an84 in track 2, which may be due to 
incomplete processing of the male C579L/6 proteins as suggested in 
figure 2.7. 
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A 15% SDS PAGE showing the molecular weight of MUPs translated in vitro 
from male C57BL/6 or Balb/c liver mRNA, cBS6 RNA or no RNA in the 
presence (+) or absence (-) of membranes. The processed MUPs (4) were 
identified by their comigration with proteins from male Salb/c urine 
and by molecular weight markers run in tracks on either side of the gel 
(not shown). 
Proteins (3) and (4) are unprocessed (3) or processed (4) products of 
MUP RNA. Without the addition of RNA protein (1) is translated and is 
therefore the product of endogenous RNA present in the reticulocyte 
lysate. Protein (5) comigrated with haernoglobin. 
The number of counts loaded were 40,000cpm (C57BL/6 and Balb/c), 
10,000cpm (cBS6 and NO RNA). After staining with coomassie blue the gel 
was soaked in amplify (Anersham) and autoradiographed for 4 days at - 
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FIGURE 2.7 
Two dimensional protein gels showing the molecular weight and 
isoelectric points of MUPS from Male C57BL/6 and Balb/c urine (c and 
or translated in vitro (in the presence of membranes) from male 
C57Bt./6 or Balb/c liver mRNAs (band d) or Mup15 RNA (f). The proteins 
were separated first by isoelectric focusing (horizontal) and then by 
molecular weight (vertical). The nomenclature of MUPs (panel (a)) is 
as Knopf et al., 1983). 
The gels were loaded with 404g of protein from urine and either 
84,000cpm (C57BL/6 and Balb2/c) or 20,000cpm (r4up15). The gels were 
stained with coomassie blue, soaked in amplify (Amersham), dried, 
autoradiographed at for 7 to 14 days at -70°C with screens (b, d and 
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urinary proteins. Proteins (6) (Figure 2.7a) are higher molecular weight 
proteins which are probably glycosylated differently in vitro and in vivo 
(see above). Proteins (8) (Figure 2.7a) are present in low amounts in in 
vitro translation products and are thought to be unprocessed or partially 
processed versions of MUPs 1 to 5. These proteins were the same size as 
unprocessed MUPs and were more basic than processed MUPs consistent with 
the presence of the leader sequence. 
DISCUSSION 
The protein products of three group 1 Balb/c MUP genes and one group 3 MUP 
gene were identified. The proteins made from three Balb/c genomic clones, 
BS1, BL1 and BS6 are MUPs 2a, 2b and 4 respectively. The protein made by 
the group 3 gene was a glycosylated MUP. Table 2.4 shows a summary of the 
protein products of nine group 1 genomic clones from Balb/c and C57BL/6 
including those identified by Held et al. (1987), Table 2.5 shows a 
summary of the group 1 subgroups. Genes in each subgroup code for protein 
products which have similar patterns of sexually dimorphic expression. 
3L6-25 and BL6-51 were both isolated from a C578L/6 library (Held et al., 
1987). It is thought that they are clones of the same gene because they 
code for the same protein (MUP2), have the same restriction map (Table 
2.4) and are identical for 880bp of 5' proximal sequence (Held et al., 
lgBl). They are members of a group 1 sub-group called Mup-1.ID (Al-Shawi 
et al., 1989; Table 2.5). MUP 2 is synthesized only in male liver. 
ELi and BJ-31 are clones of Map-I. Ic' from two different Balb/c substrains 
as mentioned in Chapter 1 (Table 1.1; Table 2.5) which code for Mup2a 
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TABLE 2.4 
GENOMIC 	cDNA 	MOUSE 	PROTEIN 	RESTRICTION MAPS 
CLONE 	CLONE 	STRAIN 	 OF GENOMIC 
CLONES 
8L6-25 
- 	 C578L/6 MU72 
3L6-51 C57BL/6 MUP2 
SANE 
BL1 cLiv5 	BALB/C MUP2a 
BJ-31 BALB/C MUP2a 
SANE 
ES1 cLivi 	BALB/C MUP2b 
BL6-11 C57BL/6 MUP3 
8L6-3 C57BL/6 MUP3 
DIFFERENT 
BL6-42 C57BL/6 MUP4 
556 BALB/C MUP4 
DIFFERENT 
- MuplS 	BALB/C, MUPG 
C57BL/6 
(Table 2.4). Clones of the C57BL/6 allelic gene Mup-1.1G (Table 1.1) 
include 5L6-11 the product of which is MUP3 (Table 2.4; Held et al., 
1987). Thus Mup-1.10b- and Mup-1.1C- code for different proteins both of 
which are present in the males and females of their respective strains 
(Table 2.5). 
The C575L/6 genomic clone BL6-3 has an identical map to the Balb/c genomic 
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clone BS6 and both clones are part of a group 1 subgroup called Mup-1. IA 
(Al-Shawl et al., 1989; Table 2.5). 570bp of the 5' proximal region of the 
two clones have been sequenced (Clark et al., 1985; Held et al., 1987). 
The two sequences differ by lbp, 2bp of which are not in the hypervariable 
region whereas they differ from Mup-1.Iti by 33bp, 9bp of which are not 
in the hypervariable region. BL6-3 codes for MUP3 which is present in male 
and female C57BL/6 urine (Held et al., 1987). BS6 codes for MUP4 which is 
present in male and female Balb/c urine. Thus members of the Mup-1.IA 
subgroup appear to have the same pattern of sexually dimorphic expression. 
The C57BL/6 genomic clone 8L6-42 codes for MUP4 (Table 2.4) which is 
barely detectable in female C57BL/6 urine (Held et al., 1987; table 2.5). 
The Balb/c genomic clone BSI codes for MUP2b (Table 2.4) which is barely 
detectable in female Balb/c urine. Both clones belong to a group 1 
subgroup called Mup-1. lB (Table 2.5) and the members of this subgroup 
appear to have a highly sexually dimorphic pattern of expression. 
There are two cases where a protein product corresponds to two group 1 
genomic clones which are not identical and belong to two different 
subgroups. In one case a clone from each strain corresponds to MUP4 (Table 
2.4). In the other case two C57BL/5 clones which are members two different 
subgroups (Mup.-1. lA and Mup-1. lc; Table 2.4; Table 2.5), correspond to 
proteins that migrate as MUP3. The expression of MLJP3 in C57BL/6 males and 
females (Table 2.5) could be due to the expression of either or both genes 
and in order to distinguish their expression a method other than 
identifying their protein products is required. This would allow the 
similar patterns of expression in males and females of members of the Mup-
1.1A and Mup-l.1C subgroups to be verified. 
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In summary, four subgroups of group 1 MUP genes have been identified 
called Mup-1. 1A, B, C, and V. In BaTh/c and C57BL/6 the proteins 
corresponding to genes in the same subgroup had similar patterns of 
sexually dimorphic expression. 
Group 3 MUP genes are expressed in the liver of both C57BL/6 and Balb/c 
mice and code for glycosylated proteins which are more acidic and higher 
in molecular weight than group I MUPs. In vitro transcribed group 3 RNA 
was translated in vitro. The group 3 protein was analysed by IEF and SDS 
PAGE and it was found to have a higher molecular weight than group 1 MUPs. 
It corresponded to one of two higher molecular weight products translated 
in vitro from both Balb/c and C57BL/6 liver RNA. This suggests that two 
different glycosylated proteins are translated in vitro from liver RNA. 
Only one type of group 3 cDNA clone has been isolated from C57BL/6 (Kuhn 
et al., 1984) and Balb/c (Shahan et al., 1987 Chave-Cox, 1986) however, 
there are at least two different group 3 genes present in Balb/c (Shi et 
al. 1989; Ma, 1987) and closely related sequences have been detected in 
C57BL/6 genomic DNA (Kuhn at al., 1984). The results shown here suggest 
that at least two group 3 genes are expressed in the liver. 
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Table 2.5 Summary of group 1 subgroups and their protein 
products 
GROUP 1 STRA- GENE GENOMIC PRO- EXPRES- 
SUB- IN CLONES TEIN SION OF 
GROUP PROTEIN 
Mup-1.1A Baib Map- B56 MUP4 M,F 
1. 74! 
C57 Mup- BL6-3 MUP3 M,F 
1. i 
Map-I. 18 	Baib Map- BS1 MUP2b M 
1.I 
C57 Map- BL6-42 MUP4 M 
I.1 
Mup-1.1C 	Baib Map- ELi, BJ- MUP2a M,F 
- 	 . 	 . 	
. I.Ic! 31 
C57 Map- CL6, MUP3 M,F 
1.10 CL13, 
BL6-11 
Mup-1.ID C57 	Map- 	BL6- 	MUP2 	M 
1. 1L 	25/51 
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BALB/C AND C57BL/6 MICE 
Male Balb/c and C57BL/6 mice excrete different sets of MtJPs (Szoka and 
Paigen, 1979; Berger and Szoka, 1981) the synthesis of which may be 
determined in three ways: 1) The two MUP alleles present in these 
strains contain distinguishable sets of coding sequences derived from 
distinct but closely related structural genes (Al-Shawi et al., 1989; 
Chapter 1). 2) The structural genes may be linked to different cis-
acting elements which affect their expression (Sampsell and Held, 
198$). 3) Different trans-acting modifiers may be available in each 
strain (Duncan et al., 1988; Szoka and Paigen, 1979; Berger and Szoka, 
1981). 
Different subgroups of the group 1 genes were shown to be regulated 
differently (Table 3.1; McIntosh and Bishop, 1989; Knopf et al., 1983) 
and the sexual dimorphic expression of protein products of specific 
besi,nilar 
subgroups of group 1 MUP genes was shown tok(Table 2.5; Al-Shawi et 
al., 1989). However, the expression of allelic subgroups in Balb/c and 
C57BL/6 mice has not been compared, neither has the expression of 
specific subgroups of group 1 genes been quantified in C57BL/6 mice. 
The levels of mRNAs in the liver made from two of the subgroups can be 
measured using oligonucleotide probes (Table 3.2; Chapter 1). The 
oligonucleotide oBL1RI hybridizes only to two genes; Mup-1. 1G and Mup-
i.icP-. The proteins specified by Mup-1.IG! and Mup-1.lCt are expressed 
in both males and females which suggests that these allelic single copy 
genes might be regulated in the same manner in the two strains. 
However, as mentioned in chapter 2, the proteins specified by Mup-l. IC! 
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and Mup-1. ic are also specified by other group 1 genes (BL6-3 and BL6-
42) and a more accurate method of comparing the expression of Mup-1. 1G 
and Mup-1.1c is to measure the mRNA levels in males and females of 
each strain using the oligonucleotide 0BL1RI. 
TABLE 3.1 Variation in MTJP expression in the livers of 
Balb/c females 
mRNA in liver copies/cell 
MALE 	 FEMALE 
PROBE 	 1 
	
2 	3 	4 
GROUP 1 cDNA 	58,000 	580 
	
8,200 	4,600 	4,300 
oBLI 	 39,000 	230 
	
9,100 	2,900 	1,700 
oBS1 	 14,000 	<15 	150 	48 	25 
The oligonucleotide oBSl was previously shown to hybridize to a highly 
sexually dimorphic MUP mRNA in Balb/c liver (McIntosh and Bishop, 
1989). Here the expression of C57BL/6 genes which hybridize with oBS1 
is compared with the expression of the Balb/c genes. Recently it was 
shown that the MUP mRNA level in female Balb/c mice varies between 
individuals (Table 3.1, GROUP 1 cDNA) (McIntosh and Bishop, 1989). 
Similar variation was not observed between individual Balb/c males 
which means that sexually dimorphic expression is variable in Balb/c 
mice. In order to determine whether variable levels of MUP expression 
occur in individual Balb/c and C57BL/6 mice, MUP proteins were isolated 
from urine. Several urine samples can be taken from one mouse over a 
period of time so that it is possible to determine to what extent MUP 
expression in one mouse changes from day to day and hence to what 
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TABLE 3.2 Group 1 MOP genes 
Mup gene 	synthesis of oligonucleotide probes 
designation 	protein 
Male(M), 	oBL1RI 	oBL1 	oBS1 
female(F) 
Mup-1.1W. 	M 
Mup-1.l-- 	- 	 - 	- 	+ 
Mup-I.1C-. 	M  
Mup-1.fl%. 	M  
extent there is variation between mice. The group 1 genes and group 3 
genes are coordinately regulated in the liver during development 
(Shahan et al., 1987b) but they respond differently to hormonal stimuli 
(Kuhn et al., 1984). The group 1 and group 3 proteins and mRNAs may 
vary differently between mice, hence the levels of group I and group 
3 proteins and mRNAs were determined separately. 
RESULTS 
Ten to four hundred microlitre samples of urine were collected from 
four mice from each sex and strain over a period of several days. The 
samples were dialysed individually and the protein concentration was 
measured after dialysis. Equal amounts (20 )ig) of protein were run on 
TEF gels, to compare the MUP components. MUPs present indifferent urine 
samples from two mice of each sex and strain are shown in Figure 3.1. 
Similar MUP patterns were observed in two additional mice from each sex 
and strain. There were10differencesin the MUP components in different 
urine samples from male and female C57BL/6 mice (samples from males 1 
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FIGURE 3.1 
Isoelectric focusing gels showing several samples of urine from the 
following mice: Male C57BL/6, 1 and 4, female C578L/6, 3 and 4, male 
Balb/c, 1 and 4 and female Balb/c, 3 and 1. Pooled urine from the same 
strain and sex of mice was loaded for comparison (P). Mups are labeled 
1 to S (group 1 proteins) and 6 (group 3 proteins). Each track 
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and 4 and females a and 4 are shown in Figure 3.1), similarly, there 
was no difference in the MUP components in different urine samples from 
male Balb/c mice (samples from mouse 1 and mouse 4 are shown in Figure 
cno.jor 
3.1). In contrast, (differences in the MUP components were observed in 
different urine samples from all four female Balb/c mice. Urine samples 
from two female Balb/c mice (1 and 3j are shown in Figure 3.1. 
The variation in MUP components is largely a differende in the amount 
of group 1 and group 3 MOPs present in each urine sample. The group 1 
MUPs are MOPs 1 to 5 and the group 3 MUPs are called MU? 6. The level 
of MU? 6 proteins in urine from female Balb/c mice varied relative to 
the group 1 proteins (in this case MOP 2 and MU? 4). Additionally MU? 
2 and MU? 4 are sometimes present in equal amounts and at other times 
there is more of MU? 4 than MUP 2. The results show that the excretion 
of different MOP proteins in female Balb/c varies between different 
urine samples. 
Three parallel northern blots of liver RNA from four mice of both sexes 
and strains are shown in Figure 3.2. The marker tracks contained RNA 
transcribed in vitro from the group 1 cDNA clones cLivl and cLiv6 
(Shahan et al., 1987) and the group 3 cDNA clone MUP15 (Chave-Cox, 
1986). An attempt was made to equalise the total amount of MU? mRNA per 
track by loading different amounts of liver RNA for each sex and strain 
(Table 3.3). The filters were re-probed with a group 1 MU? probe 
(Figure 3.2b) which showed that the strategy was largely successful 
with the main exception being two of the Balb/c females which are 
discussed further below. 
The filters were rehybridized with an Apolipoprotein Al (ApoAl) probe 
to confirm the uniformity of RNA loading (Figure 3.2c). The ApoAl probe 
is a partial cDNA clone of Apo Al (Clissold and Bishop, 1981) which is 
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FIGURE 3.2 
A comparison of sexually dimorphic MU? expression in the liver of 
C573L/6 and Balb/c mice. To examine the effect of variable expression 
in individuals on sexual dimorphism, liver RNAs from four mice (1 to 
4) of each sex and strain were compared. To compare the sexual 
dimorphism of subsets of MUP genes with total MU? and to check for 
evenness of RNA loading three identical northern blots were each 
hybridized three times (table 3.5). The first, second and third 
hybridizations are shown in figures 3.2a, b and c respectively. Mup 
expression in the liver is lower in females than males and in an 
attempt to equalize the total MU? RNA loaded in each track the 
following amounts of total liver RNA were loaded: male, 0.4pg, female 
C57BL/6, 3.2jsg, female Balb/c, 8Vg. 
FIGURE 3.2a. Subsets of MU? RNAs were detected by hybridization of the 
three filters to the following probes; oBL1RI (top), oBS1 (middle) or 
group 3 (bottom). The specificity of each hybridization was confirmed 
by hybridization to marker RNAs; cLiv6 (top), cLivi (middle) or Mup15 
(bottom). The numbers above marker tracks refer to ngs of RNA loaded. 
The MU? signal is arrowed and other bands in the top panel are due to 
background hybridization. The blots were autoradiographed at -70°C with 
screens for 3 weeks (top), 7 days (middle) or 3 days (bottom). 
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FIGURE 3.2b. The amount of group 1 MUP RNA in each sample was 
determined by rehybridizing all three blots to a group 1 probe. The 
bottom filter was stripped prior to rehybridization. The specificity 
of the hybridization was confirmed by hybridization to group 1 (cLivi 
and ci.iv6) but not group 3 (Mup15) marker RNAs. The blots were 
autoradiographed at room temperature for 3 hours (top and middle) or 
24 hours (bottom). 
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FIGURE 3.2c. The evenness of RNA loading was confirmed by rehybridizing 
the top two blots to an apolipoprotejn AX CDNA probe. The blots were 
stripped prior to rehybridization and autoradiographed for 18 hours at 
-70°C with screens. 
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TABLE 3.3 Loading of RNA 
MALE 	 FEMALE 
C57 	Balb/c 	C57 	Balb/c 
RNA loaded 	0.4 	0.4 	3.2 	8 
(Lg) 
relative 	1 	1 	8 	20 
amount of RNA 
loaded 
a component of plasma lipoproteins involved in lipid and cholesterol 
transport and is not expressed in a sexually dimorphic manner 
(Oscarsson et al. (1991). The results confirm that the same amount of 
RNA was loaded in the four tracks of each sex and strain. This means 
that the variation in MUP mRNA between the four Balb/c females (Figure 
3.2b) reflects individual variation in the level of MU? mRNA relative 
to total RNA, rather than experimental error. McIntosh and Bishop 
(1989) previously reported variation in MU? mRNA levels between 
individual Balb/c females (Table 3.1). In contrast, the apparently low 
level of MU? mRNA in male C57BL/6 mice numbers 1 and 2 and male BaTh/c 
mouse number 4 (Figure 3.2b) seems to be due to experimental error 
since it is matched by a low level of hybridization with the ApoAl 
probe (Figure 3.2c). 
The sequence in which the filters were hybridized, stripped and 
rehybridized is shown in Table 3.4. Incomplete stripping just prior to 
hybridization with the ApoAI probe is assumed to be the explanation of 
the weak signals seen in some control tracks containing run-off MU? RNA 
(Figure 3.2c). The amount of group 1 probe remaining is small and does 
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TABLE 3.4 Sequence of hybridizations to the four filters 
FILTER 
FIGURE 1 	2 3 
PROBE IN FIRST 3.2a oBL1RI 	oBS1 group 3 
HYBRIDIZATION (Mupi 5) 
STRIPPED - 	
- yes 
PROBE IN SECOND 3.2b GROIIP1 	GROUP1 GROUPI 
HYBRIDIZATION 
STRIPPED yes 	yes n.a. 
PROBE IN THIRD 	3.2c 	APO Al 	APO Al 
HYBRIDIZATION 
not affect the above conclusions (compare Figures 3.2c and 3.2b). 
The oligonucleotide probes oBL1RI and oBS1 were designed to hybridize 
to different subsets of MUP genes (Table 3.2; Chapter 1). The 
specificity of each oligonucleotide probe was confirmed by the its 
with 
hybridizationcontrol RNAs (Figure 3.2a). The group 3 and group 1 
probes contain the 5' end of the group 3 or group 1 cDNAs Mup 15 
(Chave-Cox, 1986) and cLivi (Shahan et al., 19874 respectively up to 
the EcoRI site in exon 2. The probes specifically detect group 3 
or group 1 mRNA when washes are carried out under stringent conditions 
(Ma, 1987). The specificity of both probes was confirmed by their 
hybridization with group I or group 3 control RNA respectively (Figure 
3.2b and 3.2a). 
The oligonucleotide oBL1RI hybridized to RNA in liver which is the same 
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size as control RNA (labelled MUP; Figure 3.2a). It also hybridized to 
several higher molecular weight RNAs. Hybridization to these RNAs can 
be prevented by altering the hybridization conditions (see póge 143 
ond V19vre4*This hybridization was thought to be due to non specific 
hybridization to ribosomal RNA. The oligonucleotide oBL1RI (Figure 
3.2a) hybridizes more to the tracks containing liver RNA from C57BL/6 
females than those containing liver RNA from males. This suggests that 
Map-i. ic is expressed highly in C57BL/6 females but is a relatively 
minor component in C57BL/6 males. Therefore the sexual dimorphism of 
Map-I. IG RNA is lower than total MUP. The oligonucleotide 0BL1RI 
hybridizes equally to the tracks containing male and female Balb/c 
liver RNA. This suggests that the expression of Map-I. l in common 
with total MUP is twenty times higher in male than female Balb/c liver. 
This agrees with McIntosh and Bishop (1989) who examined the expression 
of Mup-1. IG! in Balb/c mice with the oligonucleotide oBL1 and observed 
male/female ratios of 7, 13, 14 and 100. Using the above results to 
compare the sexual dimorphism of Map-i. IG and Map-I. Id suggests that 
Map-I. Ic! expression is approximately ten times more sexually dimorphic 
than Mup-i.icft expression. 
oBS1 hybridized more strongly to the tracks containing male liver RNA 
from both strains than tracks containing female liver RNA (Figure 
3.2a). Taking account of the different amounts of RNA loaded, the 
sexual dimorphism must be in the order of 100 which is considerably 
higher than the mean for all MUPs. This is in complete agreement with 
the results obtained with Balb/c mice by McIntosh and Bishop (1989). 
In summary, these results show that different group 1 genes are subject 
to different regulation. The sexual dimorphic expression of Mup-1.1C 
is in the order of 2, that of the allelic gene Mup-l. IC! is between 7 
and 20. mRNA which hybridizes with oBS1 has a total sexual dimorphism 
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of approximately 100 in both strains or mice. 
There is considerable divergence between the group 1 and group 3 genes. 
The two families respond differently to hormonal treatment and group 
3 proteins are N-glycosylated. In contrast to the levels of group 1 RNA 
which were consistent in all four C56BL/6 females (Figure 3.2b), the 
level of group 3 RNA was higher in females 1 and 4 (Figure 3.2a). The 
levels of both group 1 and group 3 RNA varied between individual Balb/c 
females (Figure 3.2a and 3.2b) but the variation in group 3 RNA was 
lower than group 1 RNA. Hence, group 3 and group 1 RNA make up varying 
proportions of total MUP RNA in different females but always make up 
the same proportions in different males. This differs from the protein 
data where it was shown that group 1 and group 3 proteins were excreted 
equally by C57BL/6 females and males and Balb/c males but excreted at 
different levels by Balb/c females. 
Clark et al. (1985) and Chave-Cox (1986) identified two different size 
classes of MU? mRNA, long and short. Short mRNA contains exons 1 to 6, 
whereas long message contains a shorter 5' region of exon 6 (6a) and 
exon 7. The short RNA has two polyadenylation signals, both of which 
are used (Clark et al., 1984) in addition some Ion 3' mRNA5 contain a 
longer version of exon 6a (Ma, 1987; Shahan et al., 1987a). An equal 
amount of two different sizes of group 1 mRNA were present in female 
Balb/c liver RNA whereas a much higher amount of long than short 
message was present in male Balb/c and male and female C57BL/6 liver 
(Figure 3.2b). Out of three Mup-1.7c! cDMA clones, two are spliced as 
the long transcript (Shahan et al., 1987a; Chave-Cox, 1986), and one 
is spliced as the short transcript (Clissold and Bishop, 1981; Chave-
Cox, 1986). It is unlikely that this is a difference in splicing 
peculiar to Balb/c females because the short cDNA clone was isolated 
from a Balb/c male and the oligonucleotide oBL1RI hybridizes more to 
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compote 
the long than the short message in the Balb/c female tracks ¶igures 
3.2a&I.It is more likely that a group 1 gene which is expressed at a 
relatively high level in Balb/c females is spliced to generate greater 
amounts of short message. 
DISCUSSION 
In female Balb/c urine the group I and group 3 proteins are not always 
present in the same proportions. The proportions vary in different 
urine samples from the same mouse. A similar effect is observed in the 
liver mRNA population where levels of group 3 message in different mice 
are much more uniform than the levels of group 1 message. It is not 
clear whether variation in the level of group 1 message is due to a 
difference between mice or reflects temporal fluctuations within the 
mice. However, the results obtained from studying MUPs in urine suggest 
that some variation occurs within each mouse. Variation may therefore 
be due to hormonal rather than genetic factors. The four mice from each 
sex and strain were housed together and killed at the same time of day, 
similarly the urine samples were taken at the same time of day on 
successive days. This suggests that the variation does not have a 
diurnal rhythm. Since the variation occurs in female mice it may relate 
to the ovarian cycle. This could be investigated. 
The results do not rule out the possibility that the variation in liver 
RNA and urinary protein are two unrelated observations. The variation 
in liver R?Th levels may be due to variable expression of MUP genes in 
different mice due to some epigenetic factors like DNA methylation. The 
variation in excretion may be due to factors which affect excretion of 
group 1 and group 3 MUPs differently. The group 3 MUPs are known to be 
glycosylated whereas the group 1 MUPs are not which could lead to 
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differences in their excretion. Differences might occur in the 
secretory pathway in hepatocytes, in plasma transport, or in the rates 
of glomerular secretion, tubular uptake or extracellular degradation 
in the kidneys. In order to compare group 1 MUP expression in 
individual Balb/c female mice it might be better to compare their total 
MUP excretion over several days with their liver RNA levels. 
Mup-1. I! and Mup-?. 1G mRNA5 are present in male and female liver RNA 
from either Balb/c or C57BL/6 mice respectively, consistent with the 
expression of their protein products (Chapter 2). In female C57BL/6 
liver RNA Mup-1. fli mRNA was the major MUP message which agrees with 
the observation that the protein specified by Mup-1.1c is the major 
protein in female C57BL/6 urine (Chapter 2). In female Balb/c mice 
there are at least two predominant messages. One was Mup-1. WE RNA 
which agrees with the presence of the protein specified by this gene 
as one of two major proteins in female Balb/c urine (Chapter 2). 
Another group 1 gene expressed in female BaTh/c liver may have the same 
sequence as the group 1 genomic clone BS6. Three pieces of evidence are 
consistent with this. 1) Chave-Cox (1986) sequenced two different group 
1 cDNA clones isolated from a female Balb/c liver cDNA library. One 
(MupB) was a partial cDNA clone of Mup-1.1C'- and the other (Mupll) had 
the same coding sequence as the genomic clone BS6. 2) Two sizes of 
group 1 MUP mRNA, long and short, were present in RNA from female 
Balb/c liver. Hybridization with specific oligonucleotide probes showed 
that Mup-1. IC- mENA is spliced mainly as the long type. Thus another 
group 1 MUP mRNA is spliced to generate the short mRNA. A MUP-hybrid 
transgene containing the 3' region of BS6 including exons 6 and 7, 
produced an equal amount of long and short mRNA in the liver. This 
indicates that the 3' sequences of BS6 can be spliced to generate both 
types of mRNA (Al-Shawi et a.!., (submitted)). 3) The protein specified 
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by BSG is one of the two major proteins in female Balb/c liver (Chapter 
2). 
TABLE 3.5 Sexual dimorphism of NUP expression 
strain xnRNA in liver (copies / c- 
ell) 	 reference 
male 	 female 
Balb/c 	30,000 	6,150 	Hastie et a- 
1., 1979 
C57BL/6 	30,000 	6,200 	Knopf et al., 
1983 
The levels of all MUP mRNAs were found to be lower in Balb/c than 
C57BL/6 females but similar in Balb/c and C57BL/6 males. An estimation 
of the sexual dimorphism of MtJP mRNA in C578L/6 liver is 8:1 compared 
with 20:1 in Balb/c liver. The levels of MUP mRNA were previously shown 
to be approximately equal in both male and female Balb/c and C578L/6 
livers (Table 3.5). The difference between these results may be due to 
different mouse colonies or it may be due to the variation between 
individual Balb/c females. 
Consistent with the expression of total group 1 mRNA in female mice, 
the expression of Mup-l. 1G in Balb/c females was found to be lower 
than that of Mup-1. It! in C57BL/6 females. In contrast the levels were 
approximately equal in males. As mentioned in the introduction the 
difference in the expression of MUP genes may be due to differences in 
cis-acting regulatory sequences present in the individual genes, the 
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MUP loci or to differences in trans-acting modifiers present in the two 
strains. MUP expression in female mice of different species varies from 
none to equal with males (Sampsell and Held, 1985). Trans-acting 
modifiers might have been introduced from matings with these species 
during the isolation of inbred strains (Watanabe et al., 1989; Nobuhara 
et al., 1989). There are several trans-acting loci in inbred strains 
of mice which affect the level of MUP excretion in females (Berger and 
Szoka, 1981; Duncan et al., 1988). Several cis-acting sequences are 
also present in MUP alleles. A cis-acting factor in the wild mouse 
species K. spretus causes the K. spretus MUP5 to be expressed at low 
levels in females (Sampsell and Held, 1985). 
It should be possible to determine if factors which cause lower 
expression of group 1 genes in Balb/c females compared with C57BL/6 
females act in cis or in trans by studying the expression of group 1 
genes in female Balb/c X C57BL/6 F 1 s. mRNA from the Balb/c gene !iup-
1. flY could be distinguished by hybridizing with oBL1 (chapter 1). mRNA 
from both Mup-1.1c and Mup-1.1c can be detected by hybridizing with 
0BL1RI. The hybridizations with oBL1 and oBL1RI could be compared to 
determine the relative expression of Mup-1. iG and Mup-1. It!. It should 
also be possible to determine whether the factors causing variation in 
group 1 expression between individual Balb/c females is transmitted in 
cis or in trans by comparing expression of Mup-I. 1t and Mup-1. It! in 
a number of Balb/c X C57BL/6 F1 females. 
The linkage group and possible identity of trans-acting modifiers could 
be determined by studying Mup- ?. It! and Mup-?. I&E expression in Balb/c 
X C57BL/6 recombinant inbred strains. In order to determine the 
identity of any cis-acting sequences, clones of the Mup-I. 1C alleles 
could be utilized to make transgenes. Several constructs containing 
part or all of a number of MUP clones have already been utilized to 
122 
THE EXPRESSION OF MUP GENES IN THE LIVER 
make transgenes which were correctl-y regulated (Shi et al., 1989; Al-
Shawl et al., 1988; Held et al., 1989). In order to distinguish mRNA 
from the NUP transgene from the endogenous MUP mRNA single or multiple 
mutations could be introduced into the transgene by site directed 
mutagenesis. If the important cis-acting sequences are present in the 
MUP clones then the expression of the transgene would be similar to the 
endogenous gene. Hybrid genes could then be made between the Mup-1. IC 
and Mup-?. flY clones which would allow different regions of each clone 
to be compared and thus determine which regions are important for the 
different patterns of expression. 
The oligonucleotide oBS1 hybridizes to five different group 1 genes in 
BaTh/c and C57BL/6 mice (Chapter 1). In agreement with previous studies 
on Balb/c mice (McIntosh and Bishop, 1969) the RNA which hybridizes to 
oBS1 is found almost exclusively in males which is consistent with the 
expression of proteins specified by genes in the Mup-1. lB subfamily in 
male but not female liver (Table 2.5). The genes which hybridize to 
oBS1 and are expressed, are highly sexually dimorphic. The presence of 
only two proteins in C57BL/6 and one in Balb/c which are very sexually 
dimorphic (Chapter 2) is consistent with the idea that many of the 
genes which hybridize with oBS1 may be silent (Shi et al., 1989). Mup-
1. 18 genomic clones could be utilized to make transgenes and the 
pattern of expression of these should be different to that expected for 
Mup-1. IC transgenes. These could also be used as above to make hybrid 
MUP genes and the regions which determine the highly sexually dimorphic 
expression of these genes could be identified. 
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HORMONE DEFICIENT MICE 
In normal rats and mice, GB secretion by the pituitary is pulsatile and 
the frequency of the pulsation is sex dependent. In female rats and mice 
the pulses of GB secretion are more frequent than in males. In female rats 
the short pulse interval leads to a level of GB in the serum which is 
almost continuous whereas in male rats a pulse of release is followed by 
a period when circulating GB is almost undetectable (Jansson et al., 
1985). The liver is able to distinguish between pulsatile and continuous 
plasma GB and in response produces two distinct patterns of gene expres-
sion, masculine and feminine, involving the expression of different 
subsets of liver genes (Jansson et al., 1988; Noshiro and Negishi, 1986; 
MacLeod and Shapiro, 1989). 
GB deficiency in mice or rats can be caused by genetic mutations affecting 
GB release (Beamer and Eicher, 1916; Schaible and Gowen, 1961; Bartke, 
1964; Camper et al., 1990; Takeuchi et al., 1990; Charlton et al., 1988), 
genetic ablation of the somatotrophs (Borrelli et al., 1989; Behringer et 
al., 1988) or by surgical removal of the hypofKysiG.'. In GB deficient 
mice or rats, the sexually dimorphic expression of GB responsive genes in 
the liver is lost. To restore sexually dimorphic gene expression, GB must 
be administered to mimic the pulsatile male or more continuous female 
pattern (Norstedt and Palmiter, 1984; Shapiro et al., 1989; Noshiro and 
Negishi, 1986; McLellan-Green et al., 1989; Oscarsson et al., 1991; 
Jansson et al., 1988; Kato et al., 1986; Waxman et al., 1989b; Robertson 
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et al., 1990). 
"Little" (lit/ lit) mice are GB deficient mutants maintained on a C578L/6 
background (Beamer and Eicher, 1976). lit/lit mice are deficient in GH but 
not in other pituitary hormones (prolactin, thyrotropin, luteinizing 
hormone or follicle stimulating hormone) (Phillips et al., 1982) or 
thyroxine (Chubb and Henry, 1987). Lit/lit mice have 8% of the GH mRNA and 
5 to 10 % of the circulating GB found in wild type mice (Cheng et al., 
1983; Phillips et al., 1982) and are unable to release GH in response to 
GRF, which is consistent with a mutation in the GRF receptor (Jansson et 
al., 1986). 
The homozygous lit mutation produces a number of phenotypic effects, 
including a loss of GB dependent growth and the sexually dimorphic 
expression of several genes in the liver (Eicher and Beamer, 1979; Jansson 
et al., 1988; Norstedt and Palmiter, 1984; Noshiro and Negishi, 1986). 
Lit/lit mice grow normally when treated with exogenous GB (Beamer et al., 
1976). The numbers and binding characteristics of GB receptors in the 
liver of lit/lit mice are similar to normal mice (Herington et al., 1983) 
and if GB is administered to mimic the secretory profiles of normal males 
or females, sexually dimorphic gene expression is induced in the liver 
(Norstedt and Palmiter, 1984; Noshiro and Negishi, 1986). 
As discussed, the pattern of MUPs in the urine and the level of MUP mRNA 
in the liver is normally sexually dimorphic with expression being higher 
in males and the females expressing a subset of the male proteins at a 
lower level. In contrast to the normal expression, both male and female 
lit/lit mice have very low levels of MUP mRNA in the liver and MUPs in the 
urine (Norstedt and Palmiter, 1984). Pulsatile administration of GB to 
125 
EXPRESSION OF MU? GENES IN GROWTH HORMONE DEFICIENT MICE 
lit/lit mice to imitate the plasma levels in normal males raised both MU? 
mRNA in the liver and MU? in urine to the male level; In contrast 
continuous administration of the same dose of GH failed to significantly 
induce MUP mENA or MU? in the urine. This level of GM administration was 
effective in inducing female specific expression since continuous 
administration of the same dose of GH to normal male mice interrupted 
their normal pulsatile plasma profile of GM and consequentially induced 
female-like numbers of ?RL-Rs in liver membranes (Norstedt and Palmiter, 
1984). 
Several MU? genes are known to be expressed in the male liver and only a 
subset of these are expressed in the female liver (Knopf et al., 1983). 
Measuring total MU? mRNA in the liver does not allow a distinction to be 
between 
madehthese two patterns of MUP expression (Norstedt and Palmiter, 1984). 
The level of MU? mRNA in lit/lit liver is much lower than in normal liver, 
however it is not known whether MUP expression is still sexually dimorphic 
in pattern (Norstedt and Palmiter, 1984). This is important because low 
levels of GM in plasma can induce sexually dimorphic expression of 
cytochrome P450s in the liver (Waxman et al., 1991) which probably 
accounts for the sexually dimorphic pattern of gene expression observed 
in the dwarf rats (Bullock et al., 1991). 
By examining MUP proteins from lit/lit urine by 1FF it is possible to 
determine whether the pattern of MU? expression is sexually dimorphic in 
lit/lit mice. The oligonucleotides described here (Chapters 1 and 3) can 
allow subsets of MU? genes with different patterns of sexually dimorphic 
expression in the liver to be examined. The oligonucleotide oBSi 
hybridizes to a subset of MU? mRNAs which are present in male but not 
female C57BL/6 liver, whereas the oligonucleotide oBr,1RI hybridizes to a 
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single MU? mRNA which is present in both male and female liver (Chapter 
3). The expression of MUPs was examined in lit/+ and lit/lit mice and was 
found to be sexually dimorphic in lit/+ but not lit/lit mice. GE was 
administered to male lit/lit mice by two different methods to imitate 
normal male or female GE secretion and this induced the MUP genes normally 
expressed in male or female lit/+ livers respectively. 
RESULTS 
Urine was collected from mutant lit/lit mice, heterozygous but phenotypi-
cally normal lit/4 mice and normal 4/~b mice. 4 indicates a mouse from 
the lit/lit colony whereas 4 indicates a C57BL/6 mouse from Banton and 
Kingman. These lines of mice have been bred separately for at least seven 
years. Urine from several mice was pooled and dialysed, then the protein 
concentration was measured. In female 4/+ and lit/4 urine the protein 
concentration was approximately 25% of the concentration in male aa and 
lit/i.! urine. In both male and female lit/lit urine the protein concentra-
tion was approximately 10% of the concentration in male ~ Mb urine. 
In order to analyse the MUP components present in normal and mutant urine 
20pg samples of urine from 4/4, lit/i.! and lit/lit male and female mice 
were analysed by means of IEF gels (Figure 4.1). The total amount of MU? 
present in 20sg of protein from lit/lit urine is lower than from or 
lit/4 urine because there are other non-MU? proteins present in urine 
which can be detected by SDS PAGE (data not shown) and make up a higher 
proportion of protein in lit/lit urine than they do in 4/a or lit/4 
urine. In urine from normal 4/4 mice and heterozygous lit/a mice, the 
MUP proteins are sexually dimorphic (Figure 4.1). The pattern of MUPs in 
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MUP proteins in urine from male and female C57BL/6, lit/+ and lit/lit 
mice and two individual male lAth mice were compared by isoelectric 
focusing. 20sg of protein was loaded in each track and the gel was 
stained with coomassje blue. 
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lit/lit urine is different from either ~6/+t or lit/,! male or female 
patterns and is not sexually dimorphic. lit/lit mice do not produce MUPs 
I and 2 which are found in urine from male i-/4 and lit/+! mice. The 
lit/lit urine does contain MUPs 3, 4, 5 and 6 which are present in both 
male and female /i- and lit/i-! urine. However the relative levels of the 
different MUPs are different from those in female lit/i-! or 4/ik urine 
(Figure 4.1). In summary, in lit/lit mice there is no sexual dimorphism 
in either the level and pattern of MUPs in urine. 
The MUPs present in urine from male and female +V+k mice differed from 
those present in urine from male and female lit/+! mice. In male lit/+! 
urine there was a lower level of MUPs 1 and 2 than in male +k/+t urine. 
Presumably this relates to the absence of Mm's 1 and 2 in male lit/lit 
urine. It therefore seems possible that the phenotype of male lit/c! mice 
is intermediate between the male lit/lit pattern and the male /+ 
pattern. A similar effect was seen in female lit/+! mice. The level of MUP 
5 was higher in female lit/lit urine than i-/~b urine and the level in 
lit/+! urine was intermediate between the two. Also MU? 3, the major 
protein in female i-/i- urine was reduced in female lit/lit urine and the 
level in lit/c! was intermediate. Thus, the pattern of MU? secretion in 
male and female lit/c! urine is intermediate between the patterns in male 
and female +t/4b and lit/lit urine respectively. 
Urine from two individual lit/+! males was examined (Tracks 7 and 8, 
Figure 4.1). The proteins in the urine from these two individual lit/+! 
mice were different. Proteins from one mouse were the same as those in 
pooled lit/c! urine, whereas those from the other mouse were the same as 
those in pooled c/c urine. Therefore the difference between pooled lit/4 
and -2/4 urine is not due to the lit mutation but to variation amongst 
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the lit/+ mice. 
TABLE 4.1 Loading of RNA 
MALE 	FEMALE 
C57, 	lit! 	C57 lit/ lit/ 
lit/a lit 	 a 	lit 
RNA loaded 0.4 	16 	3.2 8 	16 
(ug) 
relative 	1 	40 	8 	20 	40 
amount 
Two parallel northern blots were prepared containing RNA from male and 
female 4/4b, lit/4 and lit/lit mice. Again different amounts of RNA were 
loaded in each track in an attempt to equalize the loading of total MOP 
RNA per track. This was only partially successful as judged by hybridiza-
tion to a group 1 probe (Figure 4.2 IS). The RNA loading is shown in 
Table 4.1. 
The Northern blots were each hybridized twice. Blot 1 was hybridized first 
with oBS1 and then with a group 1 probe. This filter was exposed 
differently on three occasions and the photographs of all three films are 
shown (Figure 4.2, RHS). Blot 2 was hybridized first with oBL1RI and then 
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FIGURE 4.2 
A comparison of the sexual dimorphism of MU? expression in the liver 
of individual aia, lit/a and lit/lit mice. Subsets of MU? RNAs were 
detected by hybridization of two identical filters to oBS1 (top) and 
0BL1RI (middle) and then rehybridizing one filter to group 3 (bottom) 
and the other to group 1 (right hand panel, three different exposures). 
The specificity of each hybridization was confirmed by hybridization 
to marker RNAs; cL,ivl (top), cLiv6 (middle), Mup15 (bottom) or cLivi 
and cLiv6 (Right hand side). Blots were autoradiographed at -70°C with 
screens for 3 weeks (oBSi and QBL1RI) or 24 hours (group 3) or at room 
temperature (group 1) for 1 hour (top), 3 hours (middle) or 24 hours 
(bottom). Amounts of total liver RNA were loaded are indicated above 
the tracks. The numbers above marker tracks refer to ng of RNA loaded. 
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a group 3 probe (Figure 4.2). The specificity of each probe was judged by 
its ability to distinguish between homologous and non homologous RNA 
markers (Chapter 3). As a result of the differential loading of RNA the 
group 1, group 3 or oBL1RI probes hybridized more to tracks containing 
female than male ~ M and lit/4 RNA, however oBSi hybridized more to 
tracks containing male than female RNA indicating that the sexual 
dimorphism of MU? expression is similar in lit/4 and +k/+t mice. 
In contrast all four probes hybridized equally to tracks containing male 
and female lit/lit RNA indicating that there is no sexual dimorphism in 
MU? expression in lit/lit mice. RNA from the lit/lit mice hybridized very 
poorly with the group 1 probe. Compared with the ten-fold ratio in protein 
present in urine, the signal is disproportionately low relative to a 
male (for example). This is partly accounted for by a higher production 
of group 3 MUP (Figure 4.1) due presumably to the higher production of 
group 3 MUP mRNA observed (Figure 4.2). The presence of non-MU? proteins 
in the urine probably also contributes to the apparent discrepancy. 
GM is capable of inducing MU? expression in lit/lit mice (Norstedt and 
Palmiter, 1984). The pattern of GM administration determines the level of 
MU? expression. Pulsatile delivery of GM by injection to lit/lit mice 
increases MUP mRNA to normal male lit/ti levels, whereas continuous 
delivery of GM by minipump caused an insignificant increase in MU? mRNA 
(Norstedt and Palmiter, 1984), but is capable of inducing PRL-R expres-
sions to levels normally found in females. 
Experiments described here show that MUP mRNA present in male lit/4 mice 
can hybridize to both oBSl and oBL1RI whereas MUP mENA present in female 
lit/ti mice hybridizes to oSL1RI but not oBS1. Neither type of mRNA are 
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present in lit/lit mice which implies that pulsatile GH can induce both 
types of MUP mRNA but continuous Gil is unable to induce MOP mENA homolo-
gous to osSi. 
GH was administered to male lit/lit mice in either a pulsatile manner to 
mimic the normal male plasma pattern of GM or a continuous manner to mimic 
the normal female pattern. MU? mRNA levels in the liver were analysed by 
northern blots (Figure 4.3). Tht JO re3kae5 - administration 
had different effects on MOP mENA in male lit/lit mice. The levels of 
MOP mRNA in lit/lit males induced with pülsatileH were similar to those 
found in lit/+! males. The levels of MOP mRNA in lit/lit males induced 
with continuousoGil were similar to but slightly lower than those found in 
lit/ti females (Figure 4.3 (This effect is underestimated in Figure 4.3 
due to the low expression of MOP in the female lit/ti mouse shown. This 
mouse had lower levels of MU? mRNA than the lit/ti female shown in Figure 
4.2 which may indicate variation in expression between individual lit/ti 
females)). Rehybridization of the blot to an ApoAl probe showed that this 
was not due to uneven loading of RNA (Figure 4.3). 
The induction of Mops by pulsatilebGH occurs over a period of days (data 
not shown). The pulsatilebGH was administered for five days whereas the 
continuous aGE! was administered for three days which may have contributed 
to the difference in the level of induction by these two types of hormone 
treatment. The dose of continuous oGH administered was capable of over-
inducing PRL-R mRNA compared with lit/+! females (Figure 4.3) which 
indicates that this reasoning does not apply for all GH induced liver 
ffl4As. In addition different MOP mRNAs were induced by &he bjo difFeten 
rtginiessob GE! administration. mRNA from male lit/lit mice induced with 
pulsatiletGfl hybridized to both oBS1 and oBL1RI. The pattern of hybridiza- 
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FIGURE 4.3 
A comparison of the sexual dimorphism of MUP expression in the liver 
of individual lit/id mice and the effect of different patterns of GH 
administration on the pattern of MU? expression in male lit/lit mice. 
Uninduced male lit/lit mice were treated with buffer. Induced lit/lit 
mice were treated with pulsatile GH (pGH) or continuous GB (cGH). 
Subsets of MUP RNAs were detected by hybridization of two identical 
filters to oBSl and oBL1RI and rehybridizing one filter to group 1. The 
specificity of each hybridization was confirmed by hybridization to 
marker RNAs; cLivi and cLiv6. The effectiveness of continuous GM on 
gene expression in the liver was confirmed by rehybridizing both blots 
with a PRL-R cDNA probe (bottom panel). The size markers (BRL RNA 
ladder) indicated on the right of this gel showed that size of the 
major PRL-R message was approximately 2.0kb. The evenness of RNA 
loading was confirmed by rehybridizing with an apolipoprotein Al cDNA 
probe (Apo Al). 30sg of RNA was loaded per track or 30ng per marker 
track. Blots were autoradiographed at -70°C with screens for 3 hours 
(ApoAl), 5 hours (0351), 3 days (0BLIRI), 7 days (PRL-R) or at room 
temperature for 10 hours (group 1). - 
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tion was similar to lit/+! males (compare tracks 1 and 5, Figure 4.3). RNA 
from male lit/lit mice induced with continuous oGH did not hybridize to 
oBS1 but did hybridize to 0BL1RI and the pattern of hybridization was 
similar to normal lit/4 females (compare tracks 2 and 6, Figure 4.3). 
DISCUSSION 
In contrast to the situation in lit/+ mice, the expression of group 3 
genes in lit/lit mice was found to be higher than group 1 genes, which 
indicates that group . 3 genes are less dependent on GM. This agrees with 
the ten to twenty fold reduction of group 3 mRNA and the several hundred 
fold reduction in group 1 RNA observed in hypophysectomized mice (Kuhn et 
al., 1984). 
Specific oligonucleotide probes were used to study the expression of 
subsets of group 1 genes in the liver which are regulated differently by 
GM. Mup-l. ict is detected with the oligonucleotide oBL1RI. It is expressed 
in both male than female lit/+ liver although expression is higher in 
males. It is not expressed in the liver of lit/lit mice of either sex. In 
contrast, MUP genes which hybridize to the oligonucleotide oBS1 are only 
expressed in male lit/+ liver and not in livers of female lit/+ or lit/lit 
mice of either sex. Two regimes of GH administration led to an increase 
in Mup-1. 1G expression in male lit/lit mice; treatment with bGH by 
injection for five days induced much higher levels of expression than 
treatment with oGH by infusion for three days. In contrast, only one 
regime, treatment with bGH by injection for five days, induced MUP RNA 
which hybridized with oBS1. Thus, the two subsets of group 1 MUP genes, 
Map-I. 10 and genes which hybridize to oBS1 respond differently to GM. As 
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the patterns of plasma Gil are different in male and female mice (MacLeod 
et al., 1991) different levels of sexually dimorphic expression of these 
two subsets of group 1 MUP genes could be due to differences in their 
response to endogenous Gil. 
PRL-R mRNA is present at higher levels in the livers of female lit/+ mice 
than male lit/+ or lit/lit mice of either sex which is consistent with the 
levels of PRL-R in liver membranes (Norstedt and Palmiter, 1984). The two 
regimes of Gil treatment had inverse effects on PRL-R mRNA and specific MUP 
mRNAs. Treatment with oGil by infusion for three days led to higher levels 
of PRL-R mRI4A than treatment with bGH by injection for five days. This is 
consistent with levels of induction of total MUP mRNA in the liver and 
PRL-Rs in liver membranes by different regimes of bGH administration 
(Norstedt and Palmiter, 1984). 
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ISOLATION OF GENOMIC DNA 
DNA was isolated from liver by the method of Birch and Weintraub 
(1986). The tissue was rinsed in an isotonic buffer (0.15M NaCl, 0.015M 
Nacitrate, 10mM Tris Cl pH 7.4). It was homogenized by Dounce homogeni-
zation in 10mM Tris-Cl, 10mM NaCl, 3mM MgCl 2 pH 7.4, 0.5% NP40. The 
homogenate was filtered through 100)m gauze and the nuclei were 
isolated by centrifugation at 9,000 rpm at 4°C for 5 minutes. The 
nuclei were resuspended in the same buffer and recentrifuged three 
times to obtain clean nuclei. The nuclei were digested with lOOpg/ml 
pH 7G 
protease K and 2pg/ml RNaseA in 1% 505, 5rnM NaCl, SSmM Tris4,80mM EDTA 
at 65°C for 1 hour. Nuclear DNA was extracted once with a 1:1 mixture 
of phenol (equilibrated with 1M Tris-Cl pH 8.0) and chloroform and 
twice with chloroform alone. It was dialysed at 4°C overnight against 
100mM NaCl, 10mM Tris-Cl pH 7.6, 1mM EDTA, then overnight against 10mM 
Tris pH 7.6, 1mM EDTA. The DNA concentration was measured by reading 
the absorbance of an aliquot of the DNA at 260nm. The DNA was stored 
at 4 to 8°C. The length was assessed by comparing it to bacteriophage 
lambda DNA on a 0.4% Tris-borate agarose gel. 
DIGESTION OF GENOMIC DNA 
Digestions were done using the buffers and conditions supplied by the 
manufacturer. In problem digests the DNA was incubated with spermidine 
(4mm) at 37°C for 5 minutes prior to adding the other ingredients. 
Where specified, BSA (0.2%) was added with the enzyme. The extent of 
the digestion was assessed by running 0.5pg of digested DNA on an 
agarose gel and staining with ethidium bromide (50)il of lOmg/ml 
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ethidium bromide to 500m1 buffer). The gel was stained for 30 minutes 
then observed on a liv transilluminator. 
AGABOSE GEL ELECTROPHORESIS 
DNA fragments were separated by vertical or horizontal agarose gel 
electrophoresis in 1 x THE. The percentage of agarose added was varied 
to achieve the best separation of the required fragments. The gels were 
run at 25 to 35v overnight. 
SOUTHERN BLOTTING 
DNA was transferred to nylon membranes (Hybond, Ainersham), after first 
depurinating for 2 x 15 minutes (in 0.25N HC1), then neutralising for 
2 x 15 minutes (in 0.5N NaOH, 1M NaCl), and then equilibrating for 30 
minutes (in 0.5M Tris-Cl, 3mM NaCl pH 7.4). It was blotted overnight 
by capillary action (in 1.5M NaCl, 0.15M NaCitrate pH 7.0). The DNA was 
attached to the nylon by UV cross-linking for 5 to 6 minutes on a short 
wave liv trans illuminator. (The cross-linking time was worked out 
empirically). The filters were hybridized immediately or stored dry at 
room temperature. 
LABELLING OLIGONUCLEOTIDES 
The oligonucleotides were end labelled using y32P dATP and T4 polynucl-
eotide kinase (Ainersham). 30ng of oligonucleotide were labelled in 254 
using 50pCi of y32P dATP > 3000 Ci/mM (which was one molecule of y32P 
dATP per molecule of oligonucleotide) and 5 units of T4 kinase. The 
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buffer was 10mM MgCl 2 , 50mM Tris-Cl pH 7.6. The reaction incubated at 
37°C for 10 minutes. EDTA was added to 10mM, the reaction was then 
diluted to 100p1 with TE and extracted once with phenol /chloroform 
(1:1) and once with chloroform. Alternatively the probe was diluted to 
500pl with TE and separated from unincorporated nucleotides using a 
NAP-5 column (Pharmacia). The incorporation was measured before and 
after adding the enzyme by spotting 141 onto a square of 3mm paper, 
washing in 4 x 250ml cold 5% TCA, then in ethanol and ether. After 
drying at room temperature, scintillant (7.5g PPO, 750mg dimethyl POPOP 
in 2.51 toluene), was added and the cpm were measured using a 
scintillation counter. Routinely >80% of the label was incorporated. 
MEASURING THE LENGTH OF OLIGONUCLEOT IDES 
The labelled oligonucleotide (a 1/100 dilution of the labelling 
reaction) was run on a 25% acrylamide gel, containing 50% urea and I 
x THE at 1000v for approximately 1 hour. The gel was fixed for 5 
minutes in 10% methanol 10% acetic acid and autoradiographed for 5 
minutes at room temperature. Other labelled oligonucleotides were used 
as markers. 
DNA FRAGMENT PROBES 
The group 1 and group 3 specific probes contained exon 1 and half of 
exon 2 up to the EcoRI site from the cDNA clones cLivl (group 1; Shahan 
et al., 1987) and Mup 15 (group 3; Chave-cox, 1986). The Apolipoprotein 
Al probe was a 300bp partial cDNA clone from the 3' end of ApoAl 
including a stretch of 60 A residues (LVB6; Clissold and Bishop 1982). 
The PRL-R probe was a 719bp Avail to XbaI fragment of the rabbit PRL-R 
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cDNA (Edery at al., 1989) which was 77% homologous to the mouse PRL-R 
cDNA (Davis and Linzer, 1989). 
LABELLING RESTRICTION FRAGMENTS 
Restriction fragments were labelled by the method of Feinberg and 
vogeistein (1984). The labelling buffer (OLB) contained a 2:5:3 mixture 
of A:B:C. 
625111 2M Tris-HC1 pH 8.0, 25pl 514 MgCl 2 , 35011 H20 1  iBid 2-mercap-
toethanol, 5pl each of dATP, dTTP, dGTP (0.1M in 3mM Tris-HC1, 0.2mM 
EDTA pH 7.0). (Store at -20 °C). 
HEPES pH 6.6 (with NaOH) filter sterilized (Store at 4 0C). 
Hexadeoxyribonuceotides (Pharmacia) 900D units/ml in 3mM Tris HCl, 
0.2mM EDTA pH 7.0. 
The reaction was set up as follows: The DNA (30ng) and water to a final 
volume of 12pl were boiled for 3 minutes to denature the DNA, then 
chilled on ice. Gpl of OLB, i.2jsl of lOmg/ml BSA (enzyme grade), 411l 
(40jCi) of a- 32P dCTP (>3000 Ci/mMol) and lpl of klenow (1 unit) were 
added. The reaction was incubated overnight at 25°C. 
MEASURING INCORPORATION INTO FRAGMENTS 
Incorporation of a- 32P dCTP into DNA fragments was assessed by adding 
1J.Ll of the labelling reaction to intl 10% tetrasodium pyrophosphate, 
then adding 501sl Smg/ml BSA and 150jsl 100% TCA. DNA was precipitated 
on ice for 15 minutes then filtered onto a GFC filter disc. It was 
washed with lOOml 5% TCA. The radioactivity was measured by Cherenkov 
counts in a scintillation counter. io° counts/jsg were routinely 
obtained. 
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HYBRIDIZATIONS 
These were done using the method of Church and Gilbert (1984). The 
hybridization buffer contained 0.25M NaHPO 4 pH 7.2, 7% SOS and lmN 
EDTA. To reduce the background hybridization of oligonucleotides to 
rRNA lOJ.Lg/ml yeast tRNA were added to the hybridization buffer. Filters 
were pre-hybridized for 1 hour. Hybridizations were incubated overnight 
in a volume of up to 25mls per filter. The temperature of oligonucleo-
tide hybridizations depended on the length and composition of the 
oligonucleotide. The temperatures which allowed discrimination between 
two sequences varying by one nucleotide were calculated and then 
determined empirically. The temperatures used were; oBS1 52°C RNA and 
DNA, oBL1 42 °C RNA, 52°C DNA, 0BL1RI 39 °C RNA and DNA. DNA Fragment 
probes were hybridized at 68 °C except for the PRL-R cDNA probe where 
the homology of the probe to the target was only 77% (60 °C). Washes 
were carried out at the same temperatures as the hybridizations. 
Filters hybridized with ol igonucleot ides or the PRL-R probe, were 
washed as follows; two washes, 10 minutes in SOOmls of inN EDTA, 0.25M 
NaHPO4 pH 7.2 ,5% SDS; two washes, 20 minutes in 11 of 1mM EDTA, 0.25M 
NaHPO4 pH 7.2, 1%SDS. Filters hybridized with DNA fragment probes were 
washed as follows; two washes, 10 minutes in 500mls 1mM EDTA, 20mM 
NaHPO4 pH 7.2, 5% SOS, three washes, 20 minutes in 11 1mM EDTA, 20mM 
NaHPO 4 pH 7.2 1% SOS. High stringency washes were used to distinguish 
group I from group 3. These were; one wash, 20 minutes in 1mM EDTA, 
20mM NaHPO 4 pH 7.2, one wash, 20 minutes in 1mM EDTA, 6.5mM NaHPO4 pH 
7.2. 
DNA FRAGMENT ISOLATION 
Digested plasmids were electrophoresed overnight on agarose gels then 
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stained with 0.5 ug/mi Ethidium br'mide in gel buffer for 15 minutes. 
In order to locate the DNA fragments of interest but minimize DNA 
damage, gels were viewed through a thin glass plate using a long wave 
UV transilluminator. A well the length of the DNA band and approxima-
tely 3mm wide was cut on the anode side and an L-shaped piece of 
dialysis membrane was inserted with the bottom of the L facing the 
cathode. The well was filled with buffer. Electrophoresis was continued 
using filter paper wicks for 60 minutes (gels up to 1%) or 90 minutes 
(gels more than 1%). The dialysis membrane and buffer were placed in 
approximately 2ml of 0.2M NaCl, 20mM Tris pH 7.5, 1mM EDTA. The DNA 
fragment was purified using an Elutip column (Schlierer and Schule) and 
precipitated with 4 volumes of ethanol for 30 minutes at -70 0C or with 
2 volumes of ethanol overnight at -20°C. The recovery of the fragment 
was assessed by comparison with dilutions of the original digest on an 
agarose gel. 
LIGATION REACTIONS 
Ligations were carried out in a volume of 20jsl containing vector 
>0.5pmol/ml and insert >lpmol/ml. Ligation buffer was 66mM Tris pH 7.6, 
6.6mM MgCl" 10mM DTT, 0.5mM ATP. For blunt end ligations polyethylene 
glycol (PEG) was added (5%). Ligations were carried out at 16°C 
overnight. 
OF BACTERIA 
A single colony was inoculated into lOml L-broth and grown overnight. 
This was used to inoculate a 25ml culture which was grown to mid-log 
phase (OD 650nm = 0.5). The culture was chilled and bacteria pelleted 
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by centrifugation at 10K for 8 minutes at 4 °C. The bacteria were 
resuspended in half volume of ice cold 0.05M CaC1 2 . The pellet was 
vortexed prior to adding Cad 2 to aid resuspension. The bacteria were 
incubated on ice for 15 minutes then recentrifuged and resuspended in 
0.1 volume of 0.05M CaCl 2 . The competent cells were stored on ice for 
at least 45 minutes or up to one week in a refrigerator. 5 to 0.05ng 
of DNA was incubated on ice with lOOpl competent for 15 minutes 
followed by a heat shock at 37 °C for 2 minutes. lml of L-broth (37 °C) 
was added at and the bacteria were incubated for 45 minutes at 37°C to 
allow expression of resistance genes. Bacteria were centrifuged for 10 
seconds in a microcentrifuge, resuspended in 200ji1 L-broth and plated 
onto agar plates containing 100ig/ml antibiotic. For blue/white 
selection of -galactosidase activity, 50jsl of x-gal 20mg/ml in 
dimethylformamide and 201sl of IPTG 24mg/ml in H 20 were added per 
400mls. Plates were inverted and incubated overnight. 
PREPARATION OF PLASM ID DNA 
The alkaline lysis method from Sambrook et al., (1989) was used to 
prepare mini-preps of plasmid DNA. Large scale preparation of plasmid 
DNA was done as follows: 25m1s of an overnight culture of bacteria 
containing the plasmid was used to inoculate 250mls of L-broth 
containing antibiotic in a 21 flask which was shaken at 37°C for 2 
hours. Chloramphenicol 150jsg/ml was added and incubation was continued 
overnight. The next day the culture was chilled on ice then centrifuged 
at 10K, 4°C for 30 minutes. The bacterial pellet was resuspended in 
20mls of 10mM Tris-HC1, 1mM EDTA pH 7.0 then centrifuged at 10K, 4°C 
for 3 minutes. The bacterial pellet was resuspended in 4mls of sucrose 
mix (25% sucrose, 50mM Tris HCI pH 8.1, 40mM EDTA pH 8.1) and 1.2m1 of 
lOmg/ml lysozyme in sucrose mix were added. The bacteria were incubated 
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on ice for 15 minutes with occasional mixing. 1.2mls of 0.5M EDTA pH 
8.1 were added and incubation continued on ice for 5 minutes. 10.8mls 
of triton mix (2mi 10% triton, 25m1 0.5M EDTA pH 8.1, 10m1 lii Tris pH 
8.1 in lOOmls) were added. The genomic DNA was removed by centrifuga-
tion at 20K, 4°C for 60 minutes. 17.1g of Caesium chloride and 1.8mls 
of ethidium bromide 10mg/mi were added to 18mls of supernatant. The 
plasmid DNA was banded by spinning in an A50 rotor at 35K for 3 days 
at 25°C. Bands containing piasmid DNA were viewed using a long wave liv 
light and removed with a syringe and needle. The ethidiuin bromide was 
extracted with isopropanol saturated with water and caesium chloride. 
The plasmid DNA was dialysed overnight in two changes of 10mM Tris-HC1 
and then purified over a sepharose 2B column. Column buffer contained 
0.3M NaCl, 50mM Tris pH 7.4. Fractions containing the piasmid were 
located by absorption at 260nm. The plasmid DNA was then precipitated 
with 2 volumes of ethanol. 
ISOLATION OF LIVER RNA 
Tobal liver ANA was used £or northern 
This method was adapted from Chirgwin et al., (1979). 
Approximately lg of tissue or 2 plates of tissue-culture cells were 
homogenised in 4m1 of 4M guanidinium isothiocyanate containing: 25g 
guanidiniuxn isothiocyanate, 1.25m1 iN sodium citrate pH 7.0, 0.25g 
sarkosyl, 0.165m1 sigma antifoam A per SOmi. After filtration the p11 
was adjusted to 7.0 with a few p1 of 8N NaOH. This solution was stored 
for up to one month at room temperature. The RNA was purified by 
centrifugation through a caesium cushion: 1 .2m1 of 5.7M CsCl, 25mM NaAc 
were placed in an SW50 tube and 4m1 of homogenate were layered over the 
top. Balanced tubes were centrifuged for 12 hours at 36,000 rpm, 20 °C. 
After centrifugation the band containing DNA was carefully removed from 
the interface and the supernatant was decanted. The pellet of RNA was 
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resuspended by pipetting in lml of 7.5?'! guanidine hydrochloride made 
up as follows: 35.81g guanidinium HC1 made up to 50mls and then mixed 
with 1.25m1 of it'! Na 2Citrate pH 7.0 and 1.25ml 0.2M DTT. The RNA was 
precipitated by adding 25pl of iN Acetic acid and 0.5ml ethanol and 
incubating at -20 °C overnight. RNA was pelleted by centrifugation in 
an eppendorf centrifuge at 8°C and resuspended in lml sterile ddH 20. It 
was reprecipitated by adding lOOjil of 2M NaAc pH 5.0 and 3.3ml Ethanol 
and incubating at -20°C overnight. RNA was stored in 70% ethanol at - 
20°C. 
PURIFICATION OF MESSENGER RNA BY OLIGO dT CELLULOSE 
Purified mRNA was used for in vitro tranSIcLUOnS. 
This method was adapted from Berger and Kimmel (1989) p254-261. 
0.1 to ig of oligo dT cellulose (Sigma) were resuspended in 1 to Sml 
10mM Tris pH 7.4, 1mM EDTA. (ig binds 20 to 40 A 2 units of pA RNA in 
0.5M NaCl at 0°C, pH 7.5). The cellulose was placed into a small column 
and was washed overnight with DEPC treated (0.01%) sterile ddH 20. The 
RNA was resuspended in 10mM Trig pH 7.4, 1mM EDTA at lmg/ml. An equal 
volume of 2x binding buffer was added then it was heated to 70°C for 
5 minutes to denature the RNA. (Binding buffer contained 0.5M Lithium 
chloride, 0.5% SDS, 0.01M Trig pH 7.4, 1mM EDTA). The column was washed 
with lOmls binding buffer and then the RNA was applied three times. 
Following this it was washed with iSmis binding buffer and the pA RNA 
was collected in fractions of lml. The column was then washed with 
lOmls of wash buffer (0.01M Tris pH 7. 4, 0.1M LiC1, 1 M EDTA) and the 
pA RNA was collected. Finally, the pA RNA was eluted from the column 
with sterile DEPC treated TE and co-llected in lml fractions. The 
fractions containing RNA were identified by absorbance at 260nm and the 
RNA was precipitated by adding 0.1 volume of 2M NaAc pH 5.0 and 2 
volumes of ethanol. The column was washed with 20m1 0.1N NaOH to 
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hydrolyse any remaining RNA prior to reuse. PA* RNA made up between 5 
and 8% of total RNA. The pA and pA RNAs were analyzed by Northern 
blotting and hybridization which showed that the majority of MUP 
message was in the pA RNA fraction. 
RNA GEL ELECTROPHORESIS 
RNA was electrophoresed on a 1.8% agarose gel containing 6.4% formalde-
hyde and 0.0114 phosphate pH 7.0. The running buffer contained 0.01M 
phosphate pH 7.0. The RNA was denatured in 5% formaldehyde, 24% 
formamide, 0.01M phosphate pH 7.0 at 60 °C for 5 minutes then chilled 
on ice prior to loading. The gels were run at 30V overnight. 
IN VITRO TRANSCRIPTION 
The cDNAs were cloned into the vectors pTZ18R (Mead and Szczesna-
Skorupa, 1986) (cLiv6 and cLivl) or pT7-1 (Tabor and Richardson, 1985) 
(Mupl5). T7 polymerase will start transcripts preferentially with a cap 
analogue, however, uncapped RNA can also be translated in vitro. The 
plasmids were linearized at the BamHI site downstream of the insert, 
extracted with phenol /chloroform (1:1) and precipitated using ethanol. 
The RNA was transcribed from ljsg of plasmid DNA in 50pl for 180 minutes 
at 37°C. The transcription buffer contained 40mM Tris pH 7.6, 15mM 
MgCl 2 , 5mM DTT, 0.5mg/ml BSA, 1mM rNTPs and 1mM cap analogue m 7G(5')pp-
p(5')G, 50 units of Rnasin and 30 units of Ti RNA polymerase. 0.05p 
Ci/jil 32P rUT? were added to one tenth of the transcription reaction 
and ijil samples were removed at 30 minute intervals. The incorporation 
was determined as described above for DNA fragment probes. Transcrip-
tion was stopped by addition of 15mM EDTA and then phenol/chloroform 
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(1:1) extracted. RNA was precipitated with ethanol, resuspended in 
lOOjsl of 100mM NaAc pH 5.0, 5mM MgCl 2 , 50 units of RNasin, 10 units of 
ENase free DNaseI and incubated at 37°C for 10 minutes. After digestion 
of DNA, EDTA was added to 5mM and the RNA was again phenol/chloroform 
extracted. The size of the transcripts were assessed by RNA gel 
electrophoresis (as above) using other in vitro transcribed lucAs as 
size markers. The amount of RNA synthesized was calculated from the 
incorporation of 32p  UTP and also by measuring the absorption at 260nm. 
Approximately 20pg of RNA was synthesized which was both homogeneous 
and full length. 
URINE COLLECTION 
Urine was collected by bladder massage. It was dialysed overnight 
against 10mM Tris pH 7.6, 50mM NaCl, then overnight against distilled 
water. The protein concentration was measured by the method of Lowry 
(1951) using BSA as a standard. lOpl of male urine or SOjil of female 
urine in 200pl were added to lml of Lowry C. Lowry C contained 25m1 of 
Lowry A + 0.5ml Lowry B. Lowry A (29 Na 2CO3, 0.4g NaOH, 20mg Na,K,Tart-
arate in lOOml); Lowry B (0.5g Cu504 .5H20 in lOOml). After 15 minutes 
at room temperature, 0.1ml of 50% Folin and Ciocalteaus reagent were 
added. After exactly 20 minutes at room temperature, the OD was 
measured at 720nm. Urine was stored frozen at -20°C. To concentrate 
samples they were lyophilised -f or I to 2 hours in a vacuum drier and 
resuspended in a small volume of distilled water. 
IN VITRO TRANSLATION 
Translation reactions were done using a Pelham and Jackson (1976) 
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reticulocyte lysate and canine pancreatic microsomal membranes 
p&yAt 
(Amersham). The reaction contained: Lysate 20311, RNA 2.5sg (Spl), 
membranes or membrane blank (20pl), 35S-methionine 53sCi/pl (2.5311) 
(>3000 Ci/mMol). 14 samples were taken after 90 minutes using a 5311 
capillary. The samples were hydrolysed in lml 1.0 M NaOH, bleached with 
100311 30% 11202 and precipitated with TCA (10% final volume) for 30 
minutes on ice. The precipitate was filtered onto GFC filters, washed 
with lOOml 5% TCA then dried in a vacuum oven. The radioactivity was 
measured using scintillant (as above) and counting on the 14C cycle in 
a scintillation counter. The concentration of RNA used was determined 
empirically. The proteins synthesized were stored frozen at -20°C or - 
70°C. 
ONE-DIMENSIONAL FLAT BED ISOELECTRIC FOCUSING PAGE. 
Two thicknesses of IEF gel were used. The gels shown in Chapter 2 were 
1 .5mm thick. The gels shown in Chapters 3 and 4 were 0.75mm thick. The 
method used was from "Polyacrylamide Gel Electrophoresis, Laboratory 
Techniques" (pharmacia) page 32. Gels 1.5mm and 0.75mm thick had 
volumes of 15m1 and 7.5ml respectively, the stock acrylamide solution 
(SOml) contained 4.85g acrylamide, 0.15g bisacrylamide and was 
deionized for 1 hour at room temperature with 0.5g MB3 resin per 50m1. 
It was filtered and stored for up to one week at 8°C. 30m1 of gel 
solution contained 4m1 glycerol, 9.1ml double distilled water, lSml 
stock acrylamide and pharmalytes. Different combinations of pharmalytes 
were used to give the best separation. Either 0.27m1 pharmalyte 4 to 
6.5 and 1.63m1 pharmalyte 4.2 to 4.9, or 1.8ml pharmalyte 4.2 to 4.9 
and 0.2m1 pharmalyte 3.5 to 5, were used. The gel solution was degassed 
then 200311 of ammonium persulphate (22.8mg/ml) were added. The gels 
were poured using a dual slab gel electrophoresis apparatus (BioRad) 
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and could be stored for up to two months at 8 °C or used immediately. 
Gels were transferred to plastic sheets (Pharniacia PAGE-plate kit) and 
placed onto the Pharmacia flat bed gel electrophoresis apparatus which 
was pre-cooled to the running temperature (10 °C) using a refrigeration 
unit and pump. The electrode wicks were made from 1mm thick BioRad gel 
drying paper cut into strips 0.5cm x 12cm. Two strips were used for 
each electrode. The electrode wicks were soaked in electrode buffer at 
8°C. The electrode buffers were according to Pharmacia, for the longest 
pH gradient in the gel; pH 4 to 6.4 or pH 3 to 5.5. 
PH 3 to 5.5; anode iN H3P041  cathode iN glycine. 
pH 4 to 6.5; anode 0.01M DL-Glutamic acid, cathode 0.01M histidine. 
The electrode strips were blotted on 3mm paper, then placed on the gel 
surface at the anode or cathode respectively. The gel was pre-run for 
1 hour at lOntA, 1400V. The samples (up to 204) were loaded onto 
Whatman nol filter paper squares 1cm x 0.5cm which were placed onto the 
surface of the gel 1cm from the cathode electrode strip. The gel was 
run for 2 to 3 hours at lOinA, 1400v, fixed for 30 minutes in 57.5g TCA, 
17.25g sulphosalaicylic acid, 500m1 water, rinsed in destain (SOOml 
ethanol, 160ml acetic acid, to 21 with water) and stained in 400m1 
stain heated to 60 °C (lOOml of 4.6g/l coomassie blue filtered through 
Whatman nol paper, 32m1 acetic acid, water to 400m1). Gels were 
destained at 60°C, then dried on a BioRad gel drier at 80 °C. 
ROD GEL ISOELECTRIC FOCUSING 
In The Presence Of Urea 
This was done as described in Hames and Rickwood (1981) pp 201-203 with 
the following modifications; 
Instead of 0.4m1 40% ampholines pH 5 to 7 and lml 40% ampholines pH 3.5 
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to 10 the following were used; gels contained 490jsl pharmalyte 4.2 to 
4.9, 80jsl pharmalyte 4 to 6.5. sample buffer (per lml) contained 32ji1 
pharmalyte 4 to 6.5, 196ji1 pharmalyte 4.2 to 4.9. 
The rod gels were cast in glass tubes 13cm long x 3mm internal 
diameter. lml of gel solution was used per gel. The following electrode 
solutions were used; cathode, 0.0114 Histidine, anode, 0.01M glutamic 
acid. Sample overlay was not used with these electrode solutions. Gels 
were run at 25°C in a warm room. The gels were pre-focused at 200V for 
15 minutes, 300'? for 30 minutes and 400V for 1 hour. They were run at 
400'? for 14 to 18 hours then 800'? for 1 hour. 
In the absence of urea 
lOmls of gel solution contained 1.33ml 28.38% acrylamide, 1.62% 
bisacrylamide, 0.5m1 glycerol, 7.583ml ddH 20, 804 pharmalyte 4 to 6.5, 
4904 pharmalyte 4.2 to 4.9, lOjsl 10% ammonium persulphate, 74 TEMED. 
Rods and electrode solutions were as above. The samples contained: 5% 
glycerol, 0.8% pharmalyte 4 to 6.5, 4.9% pharmalyte 4.2 to 4.9. Gels 
were run as above. 
2D GEL ELECTROPHORESIS 
Prior to second dimension, rod gels, as above, were equilibrated in 
lomls of equilibration buffer. This contained 10mls glycerol, Smls 13 -
mercaptoethanol, 11.5mls 20% SDS, Smls 1.2514 Tris pH 6.75, 2.5ml 0.214 
EDTA, lml 0.514 EGTA, lml 37mg/ml PMSF in isopropanol per lOOml. 
Equilibration was carried out for 1 hour at room temperature on a 
shaking table. Gels were overlayed on the second dimension gel or 
stored at -70°C in equilibration buffer. 
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SDS DIMENSION 
Stock 30% acrylamide contained 29.2g acrylamide, 0.8g bis-acrylamide 
per lOOmi. Laemmli-type discontinuous gel buffers were used. The 
resolving gel was 15% acrylamide, 0.375M Tris-HC1 pH 8.8, 0.1% SDS. It 
was 1.5mm thick and 12cm long. The stacking gel was 4.8% acrylamide, 
0.125M Tris pH 6.75, 0.1% SDS. Gel buffer was Tris glycine, this was; 
1D gels: 0.05M Tris, 0.384M glycine 0.1% SDS, pH 8.3; 2D gels: 0.025M 
Tris, 0.19214 glycine, 0.1% SDS pH 8.3. 
The rod gel was attached to the slab gel with 1% agarose (lEF grade) 
made up with equilibrium buffer. Running dye (lml bromophenol blue 1% 
in ethanol in 9ml equilibration buffer) was laid along the top of the 
gel. The second dimension slab gels were run at by overnight. One 
dimensional slab gels were run for 12 hours at 60v or overnight at 45V. 
Gels were stained as for slab IEF gels. After staining gels were soaked 
in 500ml destain containing 7% glycerol. Radioactive gels were soaked 
in amplify (Amersham) for 30 minutes. Gels were dried for 2.5 to 3 
hours at 50 °C on the gradient cycle of a BioRad gel drier. 
MOUSE STRAINS 
C57BL/6 mice were obtained from Banton and Kingman. Balb/c mice were 
purchased from MRC laboratory animals centre, Carshalton, Surrey on 
22.09.71 and were maintained in the mouse house at Edinburgh University 
Genetics Department. Lit/lit mice were on a C57Br./6 background and were 
maintained in the Mouse House at Edinburgh University Genetics 
Department. 
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HORMONE TREATMENT 
Male lit/lit mice were treated with ovine or bovine GH (gift of U.S. 
National Pituitary Hormone Progamme) which was made up as indicated by 
the supplier. Mice were injected itraperitoneally with 100sg per 20g 
body weight every 12 hours for 5 days or infused with a sub-cutaneous 
minipump (Aizet model 10030) with 5J.Lg GH (lpl) per hour per 20g body 
weight for three days. 
BACTERIAL STRAINS 
E.Coli strain HB101 (supE44, ara-14, proA2, hsdS20, recA13, r8 ma , 
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